National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (Cth)

Case

National Health (Listing of Pharmaceutical Benefits) Instrument 2012

PB 71 of 2012

made under sections 84AF, 84AK, 85, 85A, 88 and 101 of the

National Health Act 1953

Compilation No. 131

Compilation date:   1 June 2023

Includes amendments up to:            F2023L00646

Registered:   27 June 2023

This compilation is in 7 volumes

Volume 1:       sections 1–26 and Schedule 1 (Part 1: A–C)

Volume 2:       Schedule 1 (Part 1: D–K)

Volume 3:       Schedule 1 (Part 1: L–P)

Volume 4:       Schedule 1 (Part 1: Q–Z, Part 2), Schedules 2 and 3

Volume 5:       Schedule 4 (Part 1: A–E)

Volume 6:       Schedule 4 (Part 1: F–R)

Volume 7:       Schedule 4 (Part 1: S–Z, Part 3), Schedule 5 and
   Endnotes

Each volume has its own contents

About this compilation

This compilation

This is a compilation of the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 that shows the text of the law as amended and in force on 1 June 2023 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register ( The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

Contents

1............ Name of Instrument....................................................................................................... 1

4............ Definitions..................................................................................................................... 1

5............ Drugs and medicinal preparations to which Part VII applies......................................... 2

6............ Form.............................................................................................................................. 3

7............ Manner of administration.............................................................................................. 3

8............ Brand and responsible person....................................................................................... 3

8A......... Schedule equivalent....................................................................................................... 3

9............ Authorised prescribers—Part 1 of Schedule 1.............................................................. 4

9A......... Authorised prescriber—Schedule 2............................................................................... 4

10.......... Prescription circumstances—Schedule 1....................................................................... 5

11.......... Authority required procedures....................................................................................... 5

12.......... Authority required procedures—submission of prescription......................................... 5

13.......... Authority required procedures—authorisation.............................................................. 6

14.......... Streamlined authority code............................................................................................ 8

15.......... Extended application of sections 11 to 14...................................................................... 8

16.......... Prescription circumstances—Schedule 2....................................................................... 8

17.......... Maximum quantity—Schedule 1................................................................................... 9

18.......... Maximum quantity conditions—Schedule 1.................................................................. 9

19.......... Maximum quantity—Schedule 2................................................................................. 10

20.......... Maximum number of repeats—Schedule 1................................................................. 10

21.......... Maximum number of repeats conditions—Schedule 1................................................ 11

22.......... Maximum number of repeats—Schedule 2................................................................. 11

23.......... Determined Quantity................................................................................................... 11

24.......... Pack Quantity.............................................................................................................. 12

25.......... Section 100 only supply.............................................................................................. 12

26.......... Prescriber bag only supply.......................................................................................... 13

Schedule 1—Ready‑prepared pharmaceutical benefits  15

Part 1—Ready‑prepared pharmaceutical benefits for prescription and supply     15

1  Name of Instrument

(1)  This Instrument is the National Health (Listing of Pharmaceutical Benefits) Instrument 2012.

(2)  This Instrument may also be cited as PB 71 of 2012.

4  Definitions

In this Instrument:

ABN has the same meaning as in the A New Tax System (Australian Business Number) Act 1999;

Act means the National Health Act 1953;

authorised prescriber, for a pharmaceutical benefit, means a PBS prescriber (within the meaning of Part VII of the Act) authorised under section 9 or 9A to write a prescription for the supply of the benefit;

CFC means chlorofluorocarbon;

CFU means colony forming unit;

circumstances code means the letter ‘C’ followed by a number;

conditions code means the letters ‘CN’ followed by a number;

electronic communication has the meaning given by subsection 5(1) of the Electronic Transactions Act 1999;

electronic prescription has the meaning given by the Regulations;

extemporaneously‑prepared pharmaceutical benefit means a pharmaceutical benefit other than a ready‑prepared pharmaceutical benefit;

General Statement for drugs for the treatment of hepatitis C means the statement set out in Part 3 of Schedule 4;

GP Management Plan means a comprehensive written plan for the treatment of a patient, prepared by a medical practitioner, that includes a description of the patient’s health care needs, management goals, actions to be taken by the patient and treatment and services the patient is likely to need;

I.M. means intramuscular;

I.U. means international unit;

I.V. means intravenous;

Medicare Benefits Schedule means the Health Insurance (General Medical Services Table) Regulations;

mmol means millimole;

palliative care patient means a patient with an active, progressive, far‑advanced disease for whom the prognosis is limited and the focus of care is the quality of life;

paper‑based prescription has the meaning given by the Regulations;

PBS means Pharmaceutical Benefits Scheme;

purposes code means the letter ‘P’ followed by a number;

ready‑prepared pharmaceutical benefit means a brand of a pharmaceutical item in relation to which a determination under subsection 85(6) of the Act is in force;

Regulations means the National Health (Pharmaceutical Benefits) Regulations 2017;

residential care service has the meaning given by the Regulations;

Streamlined Authority Code means the words ‘Streamlined Authority Code’ followed by a number;

Team Care Arrangements means a document prepared by a medical practitioner, following consultation with collaborating providers, that includes a description of the treatment and service goals for the patient, the treatment and services that all collaborating providers will provide and the actions to be taken by the patient;

TGA means Therapeutic Goods Administration;

WHO means World Health Organisation.

Note:          Terms used in this Instrument have the same meaning as in the Act—see section 13 of the Legislative Instruments Act 2003. These terms include:

·      Chief Executive Medicare

·      pharmaceutical benefit

·      pharmaceutical item.

  1. Drugs and medicinal preparations to which Part VII applies

(1)  For paragraph 85(2)(a) of the Act, Part VII of the Act applies to:

(a)  a drug or medicinal preparation mentioned in the column headed ‘Listed Drug’ in:

(i)  Schedule 1; or

(ii)  Part 1 of Schedule 2; and

(b)  a medicinal preparation composed of 1 or more listed drugs mentioned in subparagraph (a)(ii).

(2)  For subparagraph 85(2)(b)(i) of the Act, paragraph 85(2)(b) of the Act applies to a listed drug mentioned in subparagraph (1)(a)(ii).

(3)  For subparagraph 85(2)(b)(ii) of the Act, paragraph 85(2)(b) of the Act applies to an additive mentioned in Part 2 of Schedule 2.

Note:          Part VII of the Act applies to medicinal preparations composed of 1 or more listed drugs mentioned in subsection (2) and 1 or more of the additives mentioned in subsection (3)—see paragraph 85(2)(b) of the Act.

6  Form

For subsection 85(3) of the Act, the column headed ‘Form’ in Schedule 1 lists the form or forms for a listed drug determined for that drug.

7  Manner of administration

(1)  For subsection 85(5) of the Act, the manner of administration of a form of a listed drug mentioned in Schedule 1 is the manner of administration mentioned for that form of the drug in the column headed ‘Manner of Administration’ in Schedule 1.

(2)  For paragraph 85A(2)(c) of the Act, if a manner of administration is mentioned in Schedule 1 for a form of a listed drug, a person writing a prescription for the supply of a pharmaceutical benefit that has the listed drug in that form must, if including a manner of administration in the prescription, direct that the pharmaceutical benefit be administered in that manner.

(3)  For subsection (2), the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

8  Brand and responsible person

(1)  A brand mentioned in the column headed ‘Brand’ in Schedule 1 for a pharmaceutical item is determined for subsection 85(6) of the Act for that pharmaceutical item.

(2)  For subsection 84AF(1) of the Act, if a code is mentioned in the column in Schedule 1 headed ‘Responsible Person’ for a brand of a pharmaceutical item, the person mentioned in subsection (3) is the responsible person for the brand of the pharmaceutical item.

(3)  For subsection (2), the person is the person mentioned in Schedule 3 for the code, with the ABN, if any, mentioned in Schedule 3 for the person.

(4)  For subsections (1) and (2), the pharmaceutical item is the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

8A  Schedule equivalent

(1)  For subsection 85(6A) of the Act:

(a)  a brand of a pharmaceutical item with an ‘a’ located in the column headed ‘Schedule Equivalent’ in Schedule 1, is to be treated as equivalent to another brand of that pharmaceutical item that also has an ‘a’ located in the column headed ‘Schedule Equivalent’ in Schedule 1;

(b)  where paragraph (a) applies to a brand of a pharmaceutical item, a brand of the same pharmaceutical item with a ‘b’ in the column headed ‘Schedule equivalent’ in Schedule 1, is to be treated as equivalent to another brand of that pharmaceutical item that also has a ‘b’ located in the column headed ‘Schedule Equivalent’ in Schedule 1; and

(c)  where a brand of a pharmaceutical item appears in Schedule 5, that brand is to be treated as equivalent to any brand of any pharmaceutical item that is in the same schedule equivalent group as that brand in Schedule 5.

  1. Authorised prescribers—Part 1 of Schedule 1

(1A)  For subsection 88(1) of the Act, a medical practitioner is authorised to write a prescription for the supply of any pharmaceutical benefit mentioned in Part 1 of Schedule 1.

(1)  For subsection 88(1A) of the Act, a participating dental practitioner is authorised to write a prescription for the supply of a pharmaceutical benefit if the initials PDP are mentioned for the pharmaceutical benefit in the column headed ‘Authorised Prescriber’ in Part 1 of Schedule 1.

(2)  For subsection 88(1C) of the Act, an authorised optometrist is authorised to write a prescription for the supply of a pharmaceutical benefit if the initials AO are mentioned for the pharmaceutical benefit in the column headed ‘Authorised Prescriber’ in Part 1 of Schedule 1.

(3)  For subsection 88(1D) of the Act, an authorised midwife is authorised to write a prescription for the supply of a pharmaceutical benefit if the initials MW are mentioned for the pharmaceutical benefit in the column headed ‘Authorised Prescriber’ in Part 1 of Schedule 1.

(4)  For subsection 88(1E) of the Act, an authorised nurse practitioner is authorised to write a prescription for the supply of a pharmaceutical benefit if the initials NP are mentioned for the pharmaceutical benefit in the column headed ‘Authorised Prescriber’ in Part 1 of Schedule 1.

(5)  For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Part 1 of Schedule 1:

(a)  in the form mentioned in Part 1 of Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Part 1 of Schedule 1 for the form of the listed drug.

9A  Authorised prescriber—Schedule 2

For the purposes of subsection 88(1) of the Act, a medical practitioner is authorised to write a prescription for the supply of an extemporaneously‑prepared pharmaceutical benefit.

  1. Prescription circumstances—Schedule 1

(1)  This section applies to a pharmaceutical benefit if at least 1 circumstances code is mentioned in the column in Schedule 1 headed ‘Circumstances’ for the pharmaceutical benefit.

(2)  For paragraph 85(7)(a) of the Act, the pharmaceutical benefit is a relevant pharmaceutical benefit for the purposes of section 88A of the Act.

(3)  For paragraph 85(7)(b) of the Act, the circumstances in which a prescription for the supply of the pharmaceutical benefit may be written are the circumstances mentioned in Part 1 of Schedule 4 for at least 1 of the circumstances codes mentioned in Schedule 1 for the pharmaceutical benefit.

(4)  For subsection (1), the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

11  Authority required procedures

(1)  This section applies to a pharmaceutical benefit if the circumstances mentioned in Part 1 of Schedule 4 for a circumstances code mentioned in Schedule 1 for the pharmaceutical benefit include any of the following:

(a)  Compliance with Authority Required procedures;

(b)  Compliance with Written Authority Required procedures;

(c)  Compliance with Telephone Authority Required procedures;

(d)  Compliance with Written or Telephone Authority Required procedures.

(1A)  If the circumstances mentioned in Part 1 of Schedule 4 for a circumstances code mentioned in Schedule 1 for the pharmaceutical benefit include the words ‘Compliance with Telephone Authority Required procedures’ or ‘Compliance with Written or Telephone Authority Required procedures’ treat as if the words used are ‘Compliance with Authority Required procedures’.

Note:          If there is a Streamlined Authority Code section 14 continues to apply.

(2)  A prescription for the supply of the pharmaceutical benefit must be:

(a)  submitted by the authorised prescriber to the Chief Executive Medicare in accordance with section 12; and

(b)  authorised by the Chief Executive Medicare in accordance with section 13.

12  Authority required procedures—submission of prescription

(1)  A prescription is submitted in accordance with this subsection if:

(a)  the authorised prescriber submits to the Chief Executive Medicare:

(i)  the prescription itself; or

(ii)  for a medication chart prescription that is not an electronic prescription — the medication chart by which the prescription was written, or a copy of so much of that chart as would indicate that subsection 41(2) of the Regulations has been complied with; or

(b)  the authorised prescriber submits details of the prescription by telephone to the Chief Executive Medicare; or

(c)  the authorised prescriber submits the prescription in accordance with the instructions in an emergency telephone message provided to the authorised prescriber by the Chief Executive Medicare; or

(d)  the authorised prescriber submits details of the prescription in accordance with subsection 12(4A) to the Chief Executive Medicare, by means of electronic communication to obtain an electronic authority.

(2)  If a circumstance mentioned in Part 1 of Schedule 4 for a circumstances code applying to the pharmaceutical benefit includes Compliance with Written Authority Required procedures, the authorised prescriber must submit a prescription for the supply of the pharmaceutical benefit to the Chief Executive Medicare in accordance with paragraph (1)(a) or (d).

(3)  If a circumstance mentioned in Part 1 of Schedule 4 for a circumstances code applying to the pharmaceutical benefit includes Compliance with Telephone Authority Required procedures, the authorised prescriber must submit a prescription for the supply of the pharmaceutical benefit to the Chief Executive Medicare in accordance with paragraph (1)(b) or (c).

(4)  If a circumstance mentioned in Part 1 of Schedule 4 for a circumstances code applying to the pharmaceutical benefit includes Compliance with Written or Telephone Authority Required procedures, the authorised prescriber must submit a prescription for the supply of the pharmaceutical benefit to the Chief Executive Medicare in accordance with paragraph (1)(a), (b) or (c).

(4A)  The prescription submitted in accordance with paragraph 12(1)(d) must be:

(a)  given to the Chief Executive Medicare in writing; and

(b)  by means of an electronic communication; and

(c)  encrypted when it is given to the Chief Executive Medicare; and

(d)  in accordance with any other requirements that would need to be met in order for the requirements to give the information in writing to be taken to have been met under the Electronic Transactions Act 1999.

(5)  For paragraph (1)(a), a prescription prepared and signed by the authorised prescriber in accordance with subsection (1) is taken to have been submitted by the authorised prescriber if it is submitted by his or her employee.

13  Authority required procedures—authorisation

(1)  A paper‑based prescription (other than a prescription submitted in accordance with paragraph 12(1)(b), (c) or (d)) may be authorised by the Chief Executive Medicare signing his or her authorisation on the prescription, and:

(a)  if the Chief Executive Medicare requires the authorised prescriber to alter the prescription — returning it to the authorised prescriber for alteration before the authorised prescriber gives it to the person in respect of whom it was prepared; or

(b)  by returning it to the authorised prescriber; or

(c)  if requested by the authorised prescriber — sending it to the person in respect of whom it was prepared.

(1A)  A medication chart prescription (other than an electronic prescription, or a prescription submitted in accordance with paragraphs 12(1)(b), (c) or (d)) may be authorised by the Chief Executive Medicare signing his or her authorisation on the medication chart prescription, or a copy of the medication chart prescription, and:

(a)  if the Chief Executive Medicare requires the authorised prescriber to alter the prescription— indicating this on the medication chart prescription or copy; and

(b)  returning the medication chart or copy to the authorised prescriber for alteration.

(1B)  An electronic prescription (other than a prescription submitted in accordance with paragraphs 12(1)(b), (c) or (d)) may be authorised by the Chief Executive Medicare writing his or her authorisation on the electronic prescription, and:

(a)  if the Chief Executive Medicare requires the authorised prescriber to alter the prescription— by returning it, including by means of an electronic communication, to the authorised prescriber for alteration; or

(b)  by returning it, including by means of electronic communication to the authorised prescriber; or

(c)  if requested by the authorised prescriber — sending it to the person in respect of whom it was prepared.

(2)  A prescription submitted in accordance with paragraph 12(1)(b) may be authorised by the Chief Executive Medicare telling the authorised prescriber by telephone, at the time the Chief Executive Medicare is given details of the prescription, that the prescription is authorised.

(3)  A prescription submitted in accordance with paragraph 12(1)(d) may be authorised by the Chief Executive Medicare sending his or her authorisation, by electronic communication, including computer automated electronic communication, to the authorised prescriber.

(3A)  If the prescription submitted is declined for authorisation, the authorised prescriber may seek review of the decision by the Chief Executive Medicare.

(4)  If the Chief Executive Medicare authorises a prescription under subsection (2) or (3):

(a)  the Chief Executive Medicare must tell the authorised prescriber the number that has been allotted to the authorised prescription: and

(b)  the authorised prescriber must:

(i)  mark that number on the prescription; and

(ii)  retain a copy of the prescription showing the number marked in accordance with subparagraph (i) for 1 year from the date the prescription was authorised.

(5)  For paragraph (4)(a), the Chief Executive Medicare must tell the authorised prescriber the number:

(i)  if the authorised prescriber is an authorised optometrist—by telephone; and

(ii)  in any other case—by telephone or by electronic communication.

(6)  A prescription submitted in accordance with paragraph 12(1)(c) is taken to have been authorised by the Chief Executive Medicare if the authorised prescriber completes the prescription in accordance with the instructions given in the emergency telephone message.

14  Streamlined authority code

(1)  This section applies to a pharmaceutical benefit if the circumstances mentioned in Schedule 4 for a circumstances code applying to the pharmaceutical benefit include a Streamlined Authority Code.

(2)  The requirements of section 12 are taken to have been complied with, and the Chief Executive Medicare is taken to have authorised the prescription of the pharmaceutical benefit under section 13, if the authorised prescriber has written the Streamlined Authority Code on the prescription.

  1. Extended application of sections 11 to 14

Sections 11 to 14 apply in relation to conditions and conditions codes as if the circumstances and circumstances codes mentioned in those sections were conditions and conditions codes.

Note:             Conditions are determined in sections 18 and 21.

  1. Prescription circumstances—Schedule 2

(1)  For paragraph 85(7)(a) of the Act, a pharmaceutical benefit is a relevant pharmaceutical benefit for the purposes of section 88A if:

(a)  it is:

(i)  a listed drug mentioned in Part 1 of Schedule 2; or

(ii)  an extemporaneously‑prepared pharmaceutical benefit that contains the listed drug; and

(b)  there are circumstances mentioned for the listed drug in the column headed ‘Circumstances’ in Part 1 of Schedule 2.

(2)  For paragraph 85(7)(b) of the Act, the circumstances in which a prescription for the supply of a pharmaceutical benefit mentioned in subsection (1) may be written are:

(a)  for a listed drug mentioned in subparagraph (1)(a)(i)—the circumstances mentioned in the column headed ‘Circumstances’ in Part 1 of Schedule 2 for the drug; and

(b)  for an extemporaneously‑prepared pharmaceutical benefit mentioned in subparagraph (1)(a)(ii)—the circumstances mentioned in the column headed ‘Circumstances’ in Part 1 of Schedule 2 for each listed drug contained in the pharmaceutical benefit.

Note:          If an extemporaneously‑prepared pharmaceutical benefit contains more than one listed drug, a prescription for the supply of the pharmaceutical benefit may only be written if the circumstances mentioned for each of the listed drugs contained in the pharmaceutical benefit are met.

  1. Maximum quantity—Schedule 1

(1)  For paragraph 85A(2)(a) of the Act, the maximum quantity or number of units of the pharmaceutical item in a pharmaceutical benefit mentioned in Schedule 1 that may, in 1 prescription for the supply of the pharmaceutical benefit, be directed by an authorised prescriber to be supplied on any 1 occasion is the quantity or number of units mentioned in the column in Schedule 1 headed ‘Maximum Quantity’ for the pharmaceutical benefit and authorised prescriber.

(2)  If at least 1 purposes code is mentioned in the column in Schedule 1 headed ‘Purposes’ for a pharmaceutical benefit, the quantity or number of units mentioned in the column headed ‘Maximum Quantity’ is the maximum for the particular purposes mentioned in Schedule 4 for each purposes code.

(3)  If no purposes code is mentioned in the column in Schedule 1 headed ‘Purposes’, the quantity or number of units mentioned in the column in Schedule 1 headed ‘Maximum Quantity’ is the maximum for all purposes, other than a purpose for which a different maximum is mentioned for the same pharmaceutical benefit.

(4)  For subsection (1) the pharmaceutical item is the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

(5)  For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

  1. Maximum quantity conditions—Schedule 1

(1)  This section applies to a pharmaceutical benefit if a conditions code is mentioned in the column in Schedule 1 headed ‘Maximum Quantity’ for a maximum quantity or number of units for the pharmaceutical benefit.

(2)  For subsection 85A(2A) of the Act, the conditions which must be satisfied when writing a prescription for the supply of the pharmaceutical benefit to which a determination of a maximum quantity or number of units under paragraph 85A(2)(a) applies, are the conditions mentioned in Part 1 of Schedule 4 for the conditions code mentioned in Schedule 1 for the pharmaceutical benefit and the maximum quantity or number of units.

(3)  For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

  1. Maximum quantity—Schedule 2

(1)  For paragraph 85A(2)(a) of the Act, the maximum quantity or number of units of an extemporaneously‑prepared pharmaceutical benefit of a type mentioned in Part 3 of Schedule 2 that may, in 1 prescription for the supply of the pharmaceutical benefit, be directed by an authorised prescriber to be supplied on any 1 occasion is the quantity or number of units mentioned in the column headed ‘Maximum Quantity’ in Part 3 of Schedule 2 for that type of pharmaceutical benefit.

(2)  For subsection (1), the extemporaneously‑prepared pharmaceutical benefit is:

(a)  the listed drug mentioned in Part 1 of Schedule 2; or

(b)  an extemporaneously‑prepared pharmaceutical benefit that contains the listed drug.

  1. Maximum number of repeats—Schedule 1

(1)  For paragraph 85A(2)(b) of the Act, the maximum number of occasions an authorised prescriber may, in 1 prescription, direct that the supply of a pharmaceutical benefit mentioned in Schedule 1 be repeated is the number in the column in Schedule 1 headed ‘Number of Repeats’ for the pharmaceutical benefit and the authorised prescriber.

(2)  If at least 1 purposes code is mentioned in the column in Schedule 1 headed ‘Purposes’ for the pharmaceutical benefit, the number of repeats mentioned in the column in Schedule 1 headed ‘Number of Repeats’ is the maximum for the particular purposes mentioned in Schedule 4 for each purposes code.

(3)  If no purposes code is mentioned in the column headed ‘Purposes’, the number of repeats mentioned in the column headed ‘Number of Repeats’ is the maximum for all purposes, other than a purpose for which a different maximum is mentioned for the same pharmaceutical benefit.

(4)  For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

  1. Maximum number of repeats conditions—Schedule 1

(1)  This section applies to a pharmaceutical benefit if a conditions code is mentioned in the column in Schedule 1 headed ‘Number of Repeats’ for the maximum number of repeats for the pharmaceutical benefit.

(2)  For subsection 85A(2A) of the Act, the conditions which must be satisfied when writing a prescription for the supply of the pharmaceutical benefit to which a determination of a maximum number of repeats under paragraph 85A(2)(b) applies, are the conditions mentioned in Part 1 of Schedule 4 for the conditions code mentioned in Schedule 1 for the pharmaceutical benefit and the maximum number of repeats.

(3)  For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

  1. Maximum number of repeats—Schedule 2

(1)  For paragraph 85A(2)(b) of the Act, the maximum number of occasions an authorised prescriber may, in 1 prescription, direct that the supply of an extemporaneously‑prepared pharmaceutical benefit of a type mentioned in Part 3 of Schedule 2 be repeated is the number in the column headed ‘Number of Repeats’ in Part 3 of Schedule 2 for that type of pharmaceutical benefit.

(2)  For this section, the extemporaneously‑prepared pharmaceutical benefit is:

(a)  the listed drug mentioned in Part 1 of Schedule 2; or

(b)  an extemporaneously‑prepared pharmaceutical benefit that contains the listed drug.

23  Determined Quantity

(1)  For subsection 84AK(3) of the Act, the quantities or numbers of units of a pharmaceutical item that are determined quantities of a listed brand of the pharmaceutical item mentioned in Schedule 1 are the quantities or numbers of units mentioned in the column in Schedule 1 headed ‘Determined Quantity’ for the listed brand of the pharmaceutical item.

(2)  For this section, the listed brand of the pharmaceutical item is the brand of the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

(3)  For this section, the pharmaceutical item is the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

24  Pack Quantity

(1)  For subsection 84AK(2) of the Act, the quantities or numbers of units of a pharmaceutical item that are pack quantities of a listed brand of the pharmaceutical item mentioned in Schedule 1 are the quantities or numbers of units mentioned in the column in Schedule 1 headed ‘Pack Quantity’ for the listed brand of the pharmaceutical item.

(2)  For this section, the listed brand of the pharmaceutical item is the brand of the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

(3)  For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

  1. Section 100 only supply

(1)  For subsection 85(2A) of the Act, if the code D(100) is mentioned in the column headed ‘Section 100/Prescriber Bag only’ in Schedule 1 for a listed drug, the drug can only be supplied under special arrangements under section 100 of the Act.

(2)  For paragraph 85(8)(a) of the Act, if the code PB(100) is mentioned in the column headed ‘Section 100/Prescriber Bag only’ in Schedule 1 for a pharmaceutical benefit, the pharmaceutical benefit can only be supplied under special arrangements under section 100 of the Act.

(3)  For paragraph 85(8)(b) of the Act, if the code C(100) is mentioned in the column headed ‘Section 100/Prescriber Bag only’ in Schedule 1 for a pharmaceutical benefit, and a circumstances code is mentioned for the pharmaceutical benefit in the column headed ‘Circumstances’, the pharmaceutical benefit can be supplied in the circumstances identified in Part 1 of Schedule 4 for the circumstances code only under special arrangements under section 100 of the Act.

(4)  For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

26  Prescriber bag only supply

(1)  For subsection 85(2AA) of the Act, if one or more of the codes D(MP), D(MW) and D(NP) are mentioned in the column headed ‘Section 100/ Prescriber Bag only’ in Schedule 1 for a listed drug other than the drug methoxyflurane, then, subject to subsection (3), the drug can only be supplied by:

(a)  where the code D(MP) is mentioned, medical practitioners under section 93 of the Act, and

(b)  where the code D(MW) is mentioned, authorised midwives under section 93AA of the Act, and

(c)  where the code D(NP) is mentioned, authorised nurse practitioners under section 93AB of the Act.

Note:          A declaration in force immediately before 1 October 2012 for the purposes of subsection 85(2A) of the Act declaring that the drug methoxyflurane can only be supplied under special arrangements under section 100 of the Act, continues in force and may be dealt with on and after 1 October 2012, as if the declaration had been made for the purposes of subsection 85(2AA) of the Act and declared that methoxyflurane can only be supplied under section 93 of the Act (see Item 18 of Schedule 3 to the National Health Amendment (Pharmaceutical Benefits Scheme) Act 2012).

(2)  For subsection 85(7A) of the Act, if one or more of the codes PB(MP), PB(MW) and PB(NP) are mentioned in the column headed ‘Section 100/ Prescriber Bag only’ in Schedule 1 for a pharmaceutical benefit, then, subject to subsection (3), the pharmaceutical benefit can only be supplied by:

(a)  where the code PB(MP) is mentioned, medical practitioners under section 93 of the Act, and

(b)  where the code PB(MW) is mentioned, authorised midwives under section 93AA of the Act, and

(c)  where the code PB(NP) is mentioned, authorised nurse practitioners under section 93AB of the Act.

(3)  If :

(a)  one or more of the codes D(MP), D(MW), and D(NP) are mentioned in the column headed ‘Section 100/Prescriber Bag only’ in Schedule 1 for a listed drug; and

(b)  one or more of the codes PB(MP), PB(MW) and PB(NP) are also mentioned in the column headed ‘Section 100/Prescriber Bag only’ in Schedule 1 for a pharmaceutical benefit having the listed drug;

then:

(c)  the drug may be supplied as provided in subsection (1): and

(d)  the pharmaceutical benefit may be supplied as provided in subsection (2).

(4)  For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:

(a)  in the form mentioned in Schedule 1 for the listed drug; and

(b)  with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

Schedule 1—Ready‑prepared pharmaceutical benefits

Note:       See sections 5 to 10, 16 to 18, 20, 21 and 23 to 26.

Part 1—Ready‑prepared pharmaceutical benefits for prescription and supply

Listed Drug Form Manner of Administration Schedule Equivalent Brand Responsible Person Authorised Prescriber Circumstances Purposes Maximum Quantity Number of Repeats Pack Quantity Determined Quantity Section 100/ Prescriber Bag only
Abacavir Oral solution 20 mg (as sulfate) per mL, 240 mL Oral Ziagen VI MP NP C13920 8 5 1 D(100)
Tablet 300 mg (as sulfate) Oral Ziagen VI MP NP C4454 C4512 120 5 60 D(100)
Abacavir with lamivudine Tablet containing abacavir 600 mg (as sulfate) with lamivudine 300 mg Oral a ABACAVIR/LAMIVUDINE 600/300 SUN RA MP NP C4527 C4528 60 5 30 D(100)
a Abacavir/Lamivudine Mylan AF MP NP C4527 C4528 60 5 30 D(100)
a Kivexa VI MP NP C4527 C4528 60 5 30 D(100)
Abacavir with lamivudine and zidovudine Tablet containing abacavir 300 mg (as sulfate) with lamivudine 150 mg and zidovudine 300 mg Oral Trizivir VI MP NP C4480 C4495 120 5 60 D(100)
Abatacept Injection 125 mg in 1 mL single dose autoinjector Injection Orencia ClickJect BQ MP C8627 C8638 C8655 C8746 C11776 C11805 P8638 P8746 P11776 P11805 4 3 4
MP C8627 C8638 C8655 C8746 C11776 C11805 P8627 P8655 4 5 4
Injection 125 mg in 1 mL single dose pre‑filled syringe Injection Orencia BQ MP C8627 C8638 C8655 C8746 C11776 C11805 P8638 P8746 P11776 P11805 4 3 4
MP C8627 C8638 C8655 C8746 C11776 C11805 P8627 P8655 4 5 4
Powder for I.V. infusion 250 mg Injection Orencia BQ MP See Note 3 See Note 3 See Note 3 See Note 3 1 PB(100)
Abemaciclib Tablet 50 mg Oral Verzenio LY MP C13035 C13036 56 5 56
Tablet 100 mg Oral Verzenio LY MP C13035 C13036 56 5 56
Tablet 150 mg Oral Verzenio LY MP C13035 C13036 56 5 56
Abiraterone Tablet containing abiraterone acetate 250 mg Oral Zytiga JC MP C13945 120 2 120
Tablet containing abiraterone acetate 500 mg Oral Zytiga JC MP C13945 60 2 60
Abiraterone and methylprednisolone Pack containing 120 tablets abiraterone acetate 125 mg and 60 tablets methylprednisolone 4mg Oral Yonsa Mpred RA MP C13992 1 2 1
Acalabrutinib Capsule 100 mg Oral Calquence AP MP C10652 C12481 C12495 C12500 56 5 56
Acamprosate Tablet (enteric coated) containing acamprosate calcium 333 mg Oral a Acamprosate Mylan AL MP NP C5366 180 1 180
a APO‑Acamprosate TX MP NP C5366 180 1 180
a Campral AF MP NP C5366 180 1 180
Acarbose Tablet 50 mg Oral a Acarbose Mylan AF MP NP 90 5 90
a GLYBOSAY RW MP NP 90 5 90
Tablet 100 mg Oral a Acarbose Mylan AF MP NP 90 5 90
a Acarbose Viatris AL MP NP 90 5 90
a GLYBOSAY RW MP NP 90 5 90
Acetazolamide Tablet 250 mg Oral Diamox RW MP NP 100 3 100
Aciclovir Eye ointment 30 mg per g, 4.5 g Application to the eye a ViruPOS AE MP NP C5965 1 0 1
AO C5964 1 0 1
a XOROX IX MP NP C5965 1 0 1
AO C5964 1 0 1
Tablet 200 mg Oral a Aciclovir APOTEX TY MP NP C5936 C5942 P5936 50 0 50
a Aciclovir Sandoz HX MP NP C5936 C5942 P5936 50 0 25
a APO‑Aciclovir TX MP NP C5936 C5942 P5936 50 0 50
a Aciclovir APOTEX TY MP NP C5936 C5942 P5942 90 5 90
a Aciclovir GH GQ MP NP C5942 90 5 90
a Aciclovir Sandoz HX MP NP C5936 C5942 P5942 90 5 90
a APO‑Aciclovir TX MP NP C5936 C5942 P5942 90 5 90
a GenRx Aciclovir GX MP NP C5942 90 5 90
Tablet 800 mg Oral a Aciclovir APOTEX TY MP NP C5959 C5967 35 0 35
a Aciclovir Sandoz HX MP NP C5959 C5967 35 0 35
a APO‑Aciclovir TX MP NP C5959 C5967 35 0 35
Acitretin Capsule 10 mg Oral a Neotigason TB MP C5727 C5789 100 2 100
a ZETIN RW MP C5727 C5789 100 2 100
Capsule 25 mg Oral a Neotigason TB MP C5727 C5789 100 2 100
a ZETIN RW MP C5727 C5789 100 2 100
Aclidinium Powder for oral inhalation in breath actuated device 322 micrograms (as bromide) per dose, 60 doses Inhalation by mouth Bretaris Genuair FK MP NP C4516 1 5 1
Aclidinium with formoterol Powder for oral inhalation in breath actuated device containing aclidinium 340 micrograms (as bromide) with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses Inhalation by mouth Brimica Genuair FK MP NP C7798 1 5 1
Adalimumab Injection 20 mg in 0.2 mL pre-filled syringe Injection Humira VE MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
MP C9715 C11713 C11715 C11716 C11717 C11761 C11767 C11852 C11853 C11854 C11855 C11903 C11966 P11713 2 0 2
MP C9715 C11713 C11715 C11716 C11717 C11761 C11767 C11852 C11853 C11854 C11855 C11903 C11966 P9715 P11715 P11716 P11761 P11852 P11854 P11855 2 3 2
MP C9715 C11713 C11715 C11716 C11717 C11761 C11767 C11852 C11853 C11854 C11855 C11903 C11966 P11717 P11767 P11853 P11903 P11966 2 5 2
Injection 20 mg in 0.4 mL pre-filled syringe Injection Amgevita XT MP See Note 3 See Note 3 See Note 3 See Note 3 1 C(100)
MP C9715 C11579 C11713 C11715 C11716 C11717 C11718 C11761 C11767 C11852 C11853 C11854 C11855 C11903 C11966 P11713 2 0 1
MP C9715 C11579 C11713 C11715 C11716 C11717 C11718 C11761 C11767 C11852 C11853 C11854 C11855 C11903 C11966 P9715 P11715 P11716 P11761 P11852 P11854 P11855 2 3 1
MP C9715 C11579 C11713 C11715 C11716 C11717 C11718 C11761 C11767 C11852 C11853 C11854 C11855 C11903 C11966 P11579 P11717 P11718 P11767 P11853 P11903 P11966 2 5 1
MP C11526 C12116 2 5 1 C(100)
Injection 40 mg in 0.4 mL pre-filled pen Injection Humira VE MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Yuflyma EW MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11704 P11711 P11717 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11523 P11524 P11579 P11604 P11605 P11606 P11631 P11634 P11635 P11704 P11711 P11717 P11718 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
MP C11526 C12116 2 5 2 C(100)
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P12273 4 2 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P12273 4 2 2
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P12272 P12315 4 5 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11529 P12272 P12315 4 5 2
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P12275 P12336 P13602 P13609 6 0 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P12275 P12336 P13602 P13609 6 0 2
Injection 40 mg in 0.4 mL pre-filled syringe Injection Humira VE MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Yuflyma EW MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11704 P11711 P11717 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11523 P11524 P11579 P11604 P11605 P11606 P11631 P11634 P11635 P11704 P11711 P11717 P11718 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
MP C11526 C12116 2 5 2 C(100)
Humira VE MP C8638 C9064 C9386 C9715 C11107 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 6 0 2
Yuflyma EW MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 6 0 2
Injection 40 mg in 0.8 mL pre-filled pen Injection Amgevita XT MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Hadlima RF MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Hyrimoz SZ MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Idacio PK MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11523 P11524 P11579 P11604 P11605 P11606 P11631 P11634 P11635 P11704 P11711 P11717 P11718 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
MP C11526 C12116 2 5 2 C(100)
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11523 P11524 P11579 P11604 P11605 P11606 P11631 P11634 P11635 P11704 P11711 P11717 P11718 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
MP C11526 C12116 2 5 2 C(100)
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11523 P11524 P11579 P11604 P11605 P11606 P11631 P11634 P11635 P11704 P11711 P11717 P11718 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
MP C11526 C12116 2 5 2 C(100)
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11523 P11524 P11579 P11604 P11605 P11606 P11631 P11634 P11635 P11704 P11711 P11717 P11718 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
MP C11526 C12116 2 5 2 C(100)
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P12273 4 2 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P12273 4 2 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P12273 4 2 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P12273 4 2 2
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11529 P12272 P12315 4 5 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11529 P12272 P12315 4 5 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11529 P12272 P12315 4 5 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11529 P12272 P12315 4 5 2
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P12275 P12336 P13602 P13609 6 0 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P12275 P12336 P13602 P13609 6 0 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P12275 P12336 P13602 P13609 6 0 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11529 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C12272 C12273 C12275 C12315 C12336 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P12275 P12336 P13602 P13609 6 0 2
Injection 40 mg in 0.8 mL pre-filled syringe Injection Amgevita XT MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Hadlima RF MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Hyrimoz SZ MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Idacio PK MP See Note 3 See Note 3 See Note 3 See Note 3 2 C(100)
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11713 2 0 2
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 2 2 2
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P8638 P9064 P9386 P11810 P11861 P12131 P12174 P12194 P13550 P13599 P13606 P13648 P13650 P13681 P13682 P13694 2 3 2
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11107 P12155 P12212 P13556 P13607 P13612 P13683 2 4 2
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11523 P11524 P11579 P11604 P11605 P11606 P11631 P11634 P11635 P11704 P11711 P11717 P11718 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
MP C11526 C12116 2 5 2 C(100)
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11523 P11524 P11579 P11604 P11605 P11606 P11631 P11634 P11635 P11704 P11711 P11717 P11718 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
MP C11526 C12116 2 5 2 C(100)
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11523 P11524 P11579 P11604 P11605 P11606 P11631 P11634 P11635 P11704 P11711 P11717 P11718 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
MP C11526 C12116 2 5 2 C(100)
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P11523 P11524 P11579 P11604 P11605 P11606 P11631 P11634 P11635 P11704 P11711 P11717 P11718 P11720 P11767 P11769 P11772 P11853 P11865 P11867 P11903 P11906 P11966 P12122 P12123 P12148 P12156 P12157 P12158 P12175 P12176 P12189 P12190 P12214 P12228 P12234 P12240 2 5 2
MP C11526 C12116 2 5 2 C(100)
Amgevita XT MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 6 0 2
Hadlima RF MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 6 0 2
Hyrimoz SZ MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 6 0 2
Idacio PK MP C8638 C9064 C9386 C9715 C11107 C11523 C11524 C11579 C11604 C11605 C11606 C11631 C11634 C11635 C11704 C11709 C11711 C11713 C11715 C11716 C11717 C11718 C11720 C11759 C11761 C11767 C11769 C11772 C11810 C11852 C11853 C11854 C11855 C11861 C11865 C11867 C11903 C11906 C11966 C12098 C12101 C12122 C12123 C12131 C12147 C12148 C12155 C12156 C12157 C12158 C12174 C12175 C12176 C12189 C12190 C12194 C12212 C12214 C12228 C12234 C12240 C13550 C13556 C13599 C13602 C13606 C13607 C13609 C13612 C13648 C13650 C13681 C13682 C13683 C13694 P9715 P11709 P11715 P11716 P11759 P11761 P11852 P11854 P11855 P12098 P12101 P12147 P13602 P13609 6 0 2
Injection 80 mg in 0.8 mL pre-filled pen Injection Humira VE MP C11715 C11716 C11759 C11761 C11762 C11763 C11852 C11854 C11855 C12103 C12105 C12152 C12153 C12155 C12161 C12212 C12229 C12273 C12275 C12278 C12306 P12103 P12105 P12153 P12155 P12161 P12212 1 0 1
MP C11715 C11716 C11759 C11761 C11762 C11763 C11852 C11854 C11855 C12103 C12105 C12152 C12153 C12155 C12161 C12212 C12229 C12273 C12275 C12278 C12306 P12273 2 2 1
MP C11715 C11716 C11759 C11761 C11762 C11763 C11852 C11854 C11855 C12103 C12105 C12152 C12153 C12155 C12161 C12212 C12229 C12273 C12275 C12278 C12306 P12306 2 5 1
MP C11715 C11716 C11759 C11761 C11762 C11763 C11852 C11854 C11855 C12103 C12105 C12152 C12153 C12155 C12161 C12212 C12229 C12273 C12275 C12278 C12306 P11715 P11716 P11759 P11761 P11762 P11763 P11852 P11854 P11855 P12152 P12229 P12275 P12278 3 0 1
Injection 80 mg in 0.8 mL pre-filled syringe Injection Humira VE MP C11715 C11716 C11759 C11761 C11762 C11763 C11852 C11854 C11855 C12103 C12105 C12152 C12153 C12155 C12161 C12212 C12229 C12273 C12275 C12278 C12306 P12103 P12105 P12153 P12155 P12161 P12212 1 0 1
MP C11715 C11716 C11759 C11761 C11762 C11763 C11852 C11854 C11855 C12103 C12105 C12152 C12153 C12155 C12161 C12212 C12229 C12273 C12275 C12278 C12306 P12273 2 2 1
MP C11715 C11716 C11759 C11761 C11762 C11763 C11852 C11854 C11855 C12103 C12105 C12152 C12153 C12155 C12161 C12212 C12229 C12273 C12275 C12278 C12306 P12306 2 5 1
MP C11715 C11716 C11759 C11761 C11762 C11763 C11852 C11854 C11855 C12103 C12105 C12152 C12153 C12155 C12161 C12212 C12229 C12273 C12275 C12278 C12306 P11715 P11716 P11759 P11761 P11762 P11763 P11852 P11854 P11855 P12152 P12229 P12275 P12278 3 0 1
Adapalene with benzoyl peroxide Gel 1 mg‑25 mg per g, 30 g Application Epiduo GA MP C4898 C4961 P4961 1 1 1
MP C4898 C4961 P4898 1 3 1
NP C4898 1 3 1
Adefovir Tablet containing adefovir dipivoxil 10 mg Oral APO‑Adefovir TX MP NP C4490 C4510 60 5 30 D(100)
Adrenaline (epinephrine) I.M. injection 150 micrograms in 0.3 mL single dose syringe auto‑injector Injection a Adrenaline Jr Viatris AF MP NP C4909 C4947 C8734 2 0 1
a Anapen Junior 150 XT MP NP C4909 C4947 C8734 2 0 1
a EpiPen Jr. AL MP NP C4909 C4947 C8734 2 0 1
I.M. injection 300 micrograms in 0.3 mL single dose syringe auto‑injector Injection a Adrenaline Viatris AF MP NP C4909 C4947 C8734 2 0 1
a Anapen 300 XT MP NP C4909 C4947 C8734 2 0 1
a EpiPen AL MP NP C4909 C4947 C8734 2 0 1
I.M. injection 500 micrograms in 0.3 mL single dose syringe auto‑injector Injection Anapen 500 XT MP NP C4909 C4947 C8734 2 0 1
Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) Injection Link Medical Products Pty Ltd LM PDP MP NP 5 0 5
MP NP 5 1 5
Afatinib Tablet 20 mg Oral Giotrif BY MP C4473 C7613 28 3 28
Tablet 30 mg Oral Giotrif BY MP C4473 C7613 28 3 28
Tablet 40 mg Oral Giotrif BY MP C4473 C7613 28 3 28
Tablet 50 mg Oral Giotrif BY MP C4473 C7613 28 3 28
Aflibercept Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe Injection Eylea BN MP C13336 C13337 C13384 C13387 C13388 C13390 C13392 C13402 C13406 C13424 P13336 P13337 P13384 P13387 P13390 P13392 P13406 P13424 1 2 1
MP C13336 C13337 C13384 C13387 C13388 C13390 C13392 C13402 C13406 C13424 P13388 P13402 1 5 1
Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL) Injection Eylea BN MP C13336 C13337 C13384 C13387 C13388 C13390 C13392 C13402 C13406 C13424 P13336 P13337 P13384 P13387 P13390 P13392 P13406 P13424 1 2 1
MP C13336 C13337 C13384 C13387 C13388 C13390 C13392 C13402 C13406 C13424 P13388 P13402 1 5 1
Albendazole Tablet 200 mg Oral Zentel AS MP NP C5680 C5712 C5797 C5817 P5712 P5797 P5817 6 0 6
MP NP C5680 C5712 C5797 C5817 P5680 6 1 6
Tablet 400 mg Oral Eskazole AS MP C5607 60 2 60
Alectinib Capsule 150 mg Oral Alecensa RO MP C7345 C7346 224 3 224
Alemtuzumab Solution concentrate for I.V. infusion 12 mg in 1.2 mL Injection Lemtrada GZ MP C6847 C7714 C9589 C9636 P6847 P9589 3 0 1 D(100)
MP C6847 C7714 C9589 C9636 P7714 P9636 5 0 1 D(100)
Alendronic acid Tablet 70 mg (as alendronate sodium) Oral a Alendronate Sandoz SZ MP NP C6310 C6323 C6327 4 5 4
a APO‑Alendronate TX MP NP C6310 C6323 C6327 4 5 4
a Fonat AL MP NP C6310 C6323 C6327 4 5 4
Alendronic acid with colecalciferol Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol Oral a ALENDRONATE PLUS D3 70mg/70ug APOTEX GX MP NP C6307 C6315 C6320 4 5 4
a Alendronate Plus D3 Sandoz SZ MP NP C6307 C6315 C6320 4 5 4
a Alendronate plus D3‑DRLA RZ MP NP C6307 C6315 C6320 4 5 4
a FonatPlus AF MP NP C6307 C6315 C6320 4 5 4
a Fosamax Plus MQ MP NP C6307 C6315 C6320 4 5 4
Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol Oral a ALENDRONATE PLUS D3 70mg/140ug APOTEX GX MP NP C6306 C6319 C6325 4 5 4
a Alendronate Plus D3 Sandoz SZ MP NP C6306 C6319 C6325 4 5 4
a Alendronate plus D3‑DRLA RZ MP NP C6306 C6319 C6325 4 5 4
a FonatPlus AF MP NP C6306 C6319 C6325 4 5 4
a Fosamax Plus 70 mg/140 mcg MQ MP NP C6306 C6319 C6325 4 5 4
Alirocumab Injection 75 mg in 1 mL single use pre‑filled pen Injection Praluent SW MP C12008 C12010 C12011 C12054 2 5 2
Injection 150 mg in 1 mL single use pre‑filled pen Injection Praluent SW MP C12008 C12010 C12011 C12054 2 5 2
Allopurinol Tablet 100 mg Oral a Allopurinol APOTEX GX MP NP 200 2 200
a Allopurinol Sandoz SZ MP NP 200 2 200
a Allosig RF MP NP 200 2 200
a NOUMED ALLOPURINOL VO MP NP 200 2 200
a Progout 100 AF MP NP 200 2 200
a Zyloprim RW MP NP 200 2 200
Tablet 300 mg Oral a Allopurinol APOTEX GX MP NP 60 2 60
a Allopurinol Sandoz SZ MP NP 60 2 60
a Allosig RF MP NP 60 2 60
a NOUMED ALLOPURINOL VO MP NP 60 2 60
a Progout 300 AF MP NP 60 2 60
a Zyloprim RW MP NP 60 2 60
Alogliptin Tablet 6.25 mg (as benzoate) Oral Nesina TK MP NP C4349 28 5 28
Tablet 12.5 mg (as benzoate) Oral Nesina TK MP NP C4349 28 5 28
Tablet 25 mg (as benzoate) Oral Nesina TK MP NP C4349 28 5 28
Alogliptin with metformin Tablet containing 12.5 mg alogliptin (as benzoate) with 1 g metformin hydrochloride Oral Nesina Met 12.5/1000 TK MP NP C4423 C4427 56 5 56
Tablet containing 12.5 mg alogliptin (as benzoate) with 500 mg metformin hydrochloride Oral Nesina Met 12.5/500 TK MP NP C4423 C4427 56 5 56
Tablet containing 12.5 mg alogliptin (as benzoate) with 850 mg metformin hydrochloride Oral Nesina Met 12.5/850 TK MP NP C4423 C4427 56 5 56
Alprazolam Tablet 250 micrograms Oral Kalma 0.25 AF MP NP C6773 10 0 10
Tablet 500 micrograms Oral a Alprax 0.5 AS MP NP C6773 10 0 10
a Kalma 0.5 AF MP NP C6773 10 0 10
Tablet 1 mg Oral a Alprax 1 AS MP NP C6773 10 0 10
a Kalma 1 AF MP NP C6773 10 0 10
Amantadine Capsule containing amantadine hydrochloride 100 mg Oral Symmetrel 100 NV MP NP C5132 100 5 100
Ambrisentan Tablet 5 mg Oral a Ambrisentan Mylan AF MP See Note 3 See Note 3 See Note 3 See Note 3 30 D(100)
a Ambrisentan Viatris AL MP See Note 3 See Note 3 See Note 3 See Note 3 30 D(100)
a Cipla Ambrisentan LR MP See Note 3 See Note 3 See Note 3 See Note 3 30 D(100)
a PULMORIS YC MP See Note 3 See Note 3 See Note 3 See Note 3 30 D(100)
a Volibris ZE MP See Note 3 See Note 3 See Note 3 See Note 3 30 D(100)
Tablet 10 mg Oral a Ambrisentan Mylan AF MP See Note 3 See Note 3 See Note 3 See Note 3 30 D(100)
a Ambrisentan Viatris AL MP See Note 3 See Note 3 See Note 3 See Note 3 30 D(100)
a Cipla Ambrisentan LR MP See Note 3 See Note 3 See Note 3 See Note 3 30 D(100)
a PULMORIS YC MP See Note 3 See Note 3 See Note 3 See Note 3 30 D(100)
a Volibris ZE MP See Note 3 See Note 3 See Note 3 See Note 3 30 D(100)
Amifampridine Tablet 10 mg Oral Ruzurgi OJ MP C12979 200 5 100
Amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids Oral powder 400 g (Neocate Syneo) Oral Neocate Syneo SB MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4368 C4414 C4415 P4305 P4312 P4323 P4330 P4337 P4338 P4339 P4345 P4352 P4415 8 5 1
MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4368 C4414 C4415 P4368 P4414 12 5 1
Amino acid formula with carbohydrate, vitamins, minerals and trace elements without phenylalanine Sachets containing oral powder 20 g, 30 (PKU Go) Oral PKU Go OH MP NP C4295 4 5 1
Amino acid formula with carbohydrate without phenylalanine Tablets containing 0.92 g protein, 462 (PKU Easy Tablet) Oral PKU Easy Tablet OH MP NP C4295 4 5 1
Amino acid formula with fat, carbohydrate, vitamins, minerals, and trace elements, without methionine and supplemented with docosahexanoic acid Oral liquid 125 mL, 36 (HCU Anamix junior LQ) Oral HCU Anamix junior LQ SB MP NP C5534 4 5 1
Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine Bottles containing oral powder 34 g, 30 (PKU Easy Shake & Go) Oral PKU Easy Shake & Go OH MP NP C5970 5 5 1
Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine Bottles containing oral powder 34 g, 30 (TYR Easy Shake & Go) Oral TYR Easy Shake & Go OH MP NP C5533 4 5 1
Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine, and supplemented with docosahexanoic acid Oral liquid 125 mL, 36 (TYR Anamix junior LQ) Oral TYR Anamix junior LQ SB MP NP C5533 4 5 1
Amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides Oral powder 400 g (Alfamino Junior) Oral Alfamino Junior NT MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4415 C5945 C5974 8 5 1
Oral powder 400 g (Neocate Junior) Oral Neocate Junior SB MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4415 C5945 C5974 8 5 1
Oral powder 800 g (Essential Care Jr) Oral Essential Care Jr QH MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4415 C5945 C5974 4 5 1
Amino acid formula with fat, carbohydrate without methionine Tablets containing 0.91 g protein, 462 (HCU Easy Tablet) Oral HCU Easy Tablet OH MP NP C5534 5 5 1
Amino acid formula with fat, carbohydrate without phenylalanine Tablets (modified release), 70.8 g protein per 100 g, 110 g, 4 (PKU Easy Microtabs) Oral PKU Easy Microtabs OH MP NP C5970 7 5 1
Amino acid formula with fat, carbohydrate without phenylalanine and tyrosine Tablets containing 0.91 g protein, 462 (TYR Easy Tablet) Oral TYR Easy Tablet OH MP NP C5533 4 5 1
Amino acid formula with fat, carbohydrate without valine, leucine and isoleucine Tablets containing 0.91 g protein, 462 (MSUD Easy Tablet) Oral MSUD Easy Tablet OH MP NP C5571 5 5 1
Amino acid formula without phenylalanine Tablets 1 g, 75 (Phlexy‑10) Oral Phlexy‑10 SB MP NP C4295 24 5 1
Amino acid formula without valine, leucine and isoleucine Sachets containing oral powder 6 g, 30 (MSUD amino5) Oral MSUD amino5 VF MP NP C5571 12 5 1
Amino acid formula with vitamins and minerals, low phenylalanine and supplemented with docosahexaenoic acid and arachidonic acid Sachets containing oral powder 12.5 g, 30 (PKU Anamix First Spoon) Oral PKU Anamix First Spoon SB MP NP C4295 8 5 1
Sachets containing oral powder 12.5 g, 30 (PKU Explore 5) Oral PKU Explore 5 VF MP NP C4295 8 5 1
Sachets containing oral powder 25 g, 30 (PKU Explore 10) Oral PKU Explore 10 VF MP NP C4295 4 5 1
Amino acid formula with vitamins and minerals without lysine and low in tryptophan Oral powder 400 g (GA1 Anamix infant) Oral GA1 Anamix infant SB MP NP C5323 8 5 1
Oral powder 500 g (XLYS, LOW TRY Maxamum) Oral XLYS, LOW TRY Maxamum SB MP NP C5323 9 5 1
Sachets containing oral powder 18 g, 30 (GA1 Anamix Junior) Oral GA1 Anamix Junior NU MP NP C6007 8 5 1
Sachets containing oral powder 24 g, 30 (GA gel) Oral GA gel VF MP NP C5323 C11482 4 5 1
Sachets containing oral powder 25 g, 30 (GA express 15) Oral GA express 15 VF MP NP C5323 C11482 4 5 1
Amino acid formula with vitamins and minerals without methionine Oral liquid 87 mL, 30 (HCU cooler 10) Oral HCU cooler 10 VF MP NP C5534 4 5 1
Oral liquid 125 mL, 30 (HCU Lophlex LQ 20) Oral HCU Lophlex LQ 20 SB MP NP C5534 3 5 1
Oral liquid 130 mL, 30 (HCU cooler 15) Oral HCU cooler 15 VF MP NP C5534 4 5 1
Oral liquid 174 mL, 30 (HCU cooler 20) Oral HCU cooler 20 VF MP NP C5534 4 5 1
Oral powder 400 g (HCU Anamix infant) Oral HCU Anamix infant SB MP NP C5559 8 5 1
Oral powder 500 g (XMET Maxamum) Oral XMET Maxamum SB MP NP C5534 8 5 1
Sachets containing oral powder 24 g, 30 (HCU gel) Oral HCU gel VF MP NP C5534 4 5 1
Sachets containing oral powder 25 g, 30 (HCU express 15) Oral HCU express 15 VF MP NP C5534 4 5 1
Sachets containing oral powder 29 g, 30 (HCU Lophlex) Oral HCU Lophlex SB MP NP C6038 4 5 1
Sachets containing oral powder 36 g, 30 (HCU Anamix Junior) Oral HCU Anamix Junior NU MP NP C6038 4 5 1
Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine Oral powder 400 g (MMA/PA Anamix infant) Oral MMA/PA Anamix infant SB MP NP C5542 C5560 8 5 1
Oral powder 500 g (XMTVI Maxamum) Oral XMTVI Maxamum SB MP NP C5542 C5560 8 5 1
Sachets containing oral powder 18 g, 30 (MMA/PA Anamix Junior) Oral MMA/PA Anamix Junior NU MP NP C5986 C6055 8 5 1
Sachets containing oral powder 24 g, 30 (MMA/PA gel) Oral MMA/PA gel VF MP NP C5542 C5560 4 5 1
Sachets containing oral powder 25 g, 30 (MMA/PA express 15) Oral MMA/PA express 15 VF MP NP C5542 C5560 4 5 1
Amino acid formula with vitamins and minerals without phenylalanine Oral liquid 62.5 mL, 60 (PKU Lophlex LQ 10) Oral PKU Lophlex LQ 10 SB MP NP C4295 2 5 1
Oral liquid 87 mL, 30 (PKU Cooler 10) Oral PKU Cooler 10 VF MP NP C4295 4 5 1
Oral liquid 125 mL, 30 (PKU Lophlex LQ 20) Oral PKU Lophlex LQ 20 SB MP NP C4295 4 5 1
Oral liquid 125 mL, 36 (PKU Anamix Junior LQ) Oral PKU Anamix Junior LQ SB MP NP C4295 4 5 1
Oral liquid 130 mL, 30 (PKU Cooler 15) Oral PKU Cooler 15 VF MP NP C4295 4 5 1
Oral liquid 174 mL, 30 (PKU Air 20) Oral PKU Air 20 VF MP NP C4295 4 5 1
Oral liquid 174 mL, 30 (PKU Cooler 20) Oral PKU Cooler 20 VF MP NP C4295 4 5 1
Oral liquid 250 mL (Easiphen) Oral Easiphen SB MP NP C4295 90 5 18
Oral gel 85 g, 30 (PKU squeezie) Oral PKU squeezie VF MP NP C4295 4 5 1
Oral semi‑solid 109 g, 36 (PKU Lophlex Sensation 20) Oral PKU Lophlex Sensation 20 SB MP NP C4295 3 5 1
Oral powder 500 g (XP Maxamum) Oral XP Maxamum SB MP NP C4295 8 5 1
Sachets containing oral powder 24 g, 30 (PKU gel) Oral PKU gel VF MP NP C4295 4 5 1
Sachets containing oral powder 25 g, 30 (PKU express 15) Oral PKU express 15 VF MP NP C4295 4 5 1
Sachets containing oral powder 28 g, 30 (PKU Lophlex) Oral PKU Lophlex SB MP NP C4295 4 5 1
Sachets containing oral powder 34 g, 30 (PKU express 20) Oral PKU express 20 VF MP NP C4295 4 5 1
Sachets containing oral powder 36 g, 30 (PKU Anamix Junior) Oral PKU Anamix Junior SB MP NP C4964 4 5 1
Amino acid formula with vitamins and minerals without phenylalanine and tyrosine Oral liquid 87 mL, 30 (TYR cooler 10) Oral TYR cooler 10 VF MP NP C5533 4 5 1
Oral liquid 125 mL, 30 (TYR Lophlex LQ 20) Oral TYR Lophlex LQ 20 SB MP NP C5533 3 5 1
Oral liquid 130 mL, 30 (TYR cooler 15) Oral TYR cooler 15 VF MP NP C5533 4 5 1
Oral liquid 174 mL, 30 (TYR cooler 20) Oral TYR cooler 20 VF MP NP C5533 4 5 1
Oral powder 400 g (TYR Anamix infant) Oral TYR Anamix infant SB MP NP C5533 8 5 1
Oral powder 500 g (XPhen, Tyr Maxamum) Oral XPhen, Tyr Maxamum SB MP NP C5533 8 5 1
Sachets containing oral powder 24 g, 30 (TYR gel) Oral TYR gel VF MP NP C5533 4 5 1
Sachets containing oral powder 25 g, 30 (TYR express 15) Oral TYR express 15 VF MP NP C5533 4 5 1
Sachets containing oral powder 28 g, 30 (TYR Lophlex) Oral TYR Lophlex SB MP NP C5533 4 5 1
Sachets containing oral powder 36 g, 30 (TYR Anamix Junior) Oral TYR Anamix Junior SB MP NP C4923 4 5 1
Amino acid formula with vitamins and minerals without valine, leucine and isoleucine Oral liquid 87 mL, 30 (MSUD cooler 10) Oral MSUD cooler 10 VF MP NP C5571 4 5 1
Oral liquid 125 mL, 30 (MSUD Lophlex LQ 20) Oral MSUD Lophlex LQ 20 SB MP NP C5571 3 5 1
Oral liquid 130 mL, 30 (MSUD cooler 15) Oral MSUD cooler 15 VF MP NP C5571 4 5 1
Oral liquid 174 mL, 30 (MSUD cooler 20) Oral MSUD cooler 20 VF MP NP C5571 4 5 1
Oral powder 400 g (MSUD Anamix infant) Oral MSUD Anamix infant SB MP NP C5571 8 5 1
Oral powder 500 g (MSUD AID III) Oral MSUD AID III SB MP NP C5571 4 5 1
Oral powder 500 g (MSUD Maxamum) Oral MSUD Maxamum SB MP NP C5571 8 5 1
Sachets containing oral powder 24 g, 30 (MSUD gel) Oral MSUD gel VF MP NP C5571 4 5 1
Sachets containing oral powder 25 g, 30 (MSUD express 15) Oral MSUD express 15 VF MP NP C5571 4 5 1
Sachets containing oral powder 28 g, 30 (MSUD Lophlex) Oral MSUD Lophlex SB MP NP C5571 4 5 1
Sachets containing oral powder 36 g, 30 (MSUD Anamix Junior) Oral MSUD Anamix Junior SB MP NP C4954 4 5 1
Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid Oral liquid 125 mL, 36 (MSUD Anamix Junior LQ) Oral MSUD Anamix Junior LQ SB MP NP C5571 4 5 1
Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine Oral powder 400 g (PKU Anamix infant) Oral PKU Anamix infant SB MP NP C4295 8 5 1
Oral powder 400 g (PKU Start) Oral PKU Start VF MP NP C4295 8 5 1
Amino acids‑synthetic, formula Oral powder 400 g (EleCare) Oral EleCare AB MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4368 C4414 C4415 P4305 P4312 P4323 P4330 P4337 P4338 P4339 P4345 P4352 P4415 8 5 1
MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4368 C4414 C4415 P4368 P4414 12 5 1
Oral powder 400 g (Neocate Junior Vanilla) Oral Neocate Junior Vanilla SB MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4368 C4414 C4415 P4305 P4312 P4323 P4330 P4337 P4338 P4339 P4345 P4352 P4415 8 5 1
MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4368 C4414 C4415 P4368 P4414 12 5 1
Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids Oral powder 400 g (EleCare LCP) Oral EleCare LCP AB MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4415 8 5 1
Oral powder 400 g (Neocate LCP) Oral Neocate LCP SB MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4415 8 5 1
Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides Oral powder 400 g (Alfamino) Oral Alfamino NT MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4415 C5945 C5974 8 5 1
Oral powder 400 g (Neocate Gold) Oral Neocate Gold SB MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4368 C4414 C4415 P4305 P4312 P4323 P4330 P4337 P4338 P4339 P4345 P4352 P4415 8 5 1
MP NP C4305 C4312 C4323 C4330 C4337 C4338 C4339 C4345 C4352 C4368 C4414 C4415 P4368 P4414 12 5 1
Amiodarone Tablet containing amiodarone hydrochloride 100 mg Oral a Aratac 100 AF MP NP C5665 30 5 30
a Cordarone X 100 SW MP NP C5665 30 5 30
Tablet containing amiodarone hydrochloride 200 mg Oral a Amdarone XT MP NP C5665 30 5 30
a Amiodarone Sandoz SZ MP NP C5665 30 5 30
a APO‑Amiodarone TX MP NP C5665 30 5 30
a Aratac 200 AF MP NP C5665 30 5 30
a Cordarone X 200 SW MP NP C5665 30 5 30
Amisulpride Oral solution 100 mg per mL, 60 mL Oral Solian Solution SW MP NP C4246 2 5 1
Tablet 100 mg Oral a Amisulpride 100 Winthrop WA MP NP C4246 30 5 30
a Amisulpride Sandoz Pharma HX MP NP C4246 30 5 30
a APO‑Amisulpride TX MP NP C4246 30 5 30
a Solian 100 SW MP NP C4246 30 5 30
a Sulprix AF MP NP C4246 30 5 30
Tablet 200 mg Oral a Amisulpride Sandoz Pharma HX MP NP C4246 60 5 60
a APO‑Amisulpride TX MP NP C4246 60 5 60
a Solian 200 SW MP NP C4246 60 5 60
a Sulprix AF MP NP C4246 60 5 60
Tablet 400 mg Oral a Amipride 400 RW MP NP C4246 60 5 60
a Amisulpride 400 Winthrop WA MP NP C4246 60 5 60
a Amisulpride Sandoz Pharma HX MP NP C4246 60 5 60
a APO‑Amisulpride TX MP NP C4246 60 5 60
a Solian 400 SW MP NP C4246 60 5 60
a Sulprix AF MP NP C4246 60 5 60
Amitriptyline Tablet containing amitriptyline hydrochloride 10 mg Oral a Amitriptyline Lupin GQ MP NP 50 2 50
a Amitriptyline Viatris 10 AL MP NP 50 2 50
a APO‑Amitriptyline 10 TX MP NP 50 2 50
a APX‑Amitriptyline TY MP NP 50 2 50
a Endep 10 AF MP NP 50 2 50
a ENTRIP RW MP NP 50 2 50
Tablet containing amitriptyline hydrochloride 25 mg Oral a Amitriptyline Alphapharm 25 MQ MP NP 50 2 50
a Amitriptyline Lupin GQ MP NP 50 2 50
a Amitriptyline Viatris 25 AL MP NP 50 2 50
a APO‑Amitriptyline 25 TX MP NP 50 2 50
a APX‑Amitriptyline TY MP NP 50 2 50
a Endep 25 AF MP NP 50 2 50
a ENTRIP RW MP NP 50 2 50
Tablet containing amitriptyline hydrochloride 50 mg Oral a Amitriptyline Lupin GQ MP NP 50 2 50
a Amitriptyline Viatris 50 AL MP NP 50 2 50
a APO‑Amitriptyline 50 TX MP NP 50 2 50
a APX‑Amitriptyline TY MP NP 50 2 50
a Endep 50 AF MP NP 50 2 50
a ENTRIP RW MP NP 50 2 50
Amlodipine Tablet 5 mg (as besilate) Oral a Amlo 5 RW MP NP 30 5 30
a Amlodipine Amneal EF MP NP 30 5 30
a Amlodipine APOTEX GX MP NP 30 5 30
a Amlodipine GH GQ MP NP 30 5 30
a Amlodipine Sandoz SZ MP NP 30 5 30
a APO‑Amlodipine TX MP NP 30 5 30
a Blooms Amlodipine BG MP NP 30 5 30
a Blooms the Chemist Amlodipine IB MP NP 30 5 30
a BTC Amlodipine JB MP NP 30 5 30
a Nordip AF MP NP 30 5 30
a Norvapine ED MP NP 30 5 30
a Norvasc AS MP NP 30 5 30
a NOUMED AMLODIPINE VO MP NP 30 5 30
a Pharmacor Amlodipine CR MP NP 30 5 30
Tablet 10 mg (as besilate) Oral a Amlo 10 RW MP NP 30 5 30
a Amlodipine Amneal EF MP NP 30 5 30
a Amlodipine APOTEX GX MP NP 30 5 30
a Amlodipine GH GQ MP NP 30 5 30
a Amlodipine Sandoz SZ MP NP 30 5 30
a APO‑Amlodipine TX MP NP 30 5 30
a Blooms Amlodipine BG MP NP 30 5 30
a Blooms the Chemist Amlodipine IB MP NP 30 5 30
a BTC Amlodipine JB MP NP 30 5 30
a Nordip AF MP NP 30 5 30
a Norvapine ED MP NP 30 5 30
a Norvasc AS MP NP 30 5 30
a NOUMED AMLODIPINE VO MP NP 30 5 30
a Pharmacor Amlodipine CR MP NP 30 5 30
Amlodipine with atorvastatin Tablet 5 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) Oral Cadivast 5/10 AF MP NP 30 5 30
Tablet 5 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) Oral Cadivast 5/20 AF MP NP 30 5 30
Tablet 5 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) Oral a Cadivast 5/40 AF MP NP 30 5 30
a Caduet 5/40 AS MP NP 30 5 30
Tablet 5 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) Oral a Cadivast 5/80 AF MP NP 30 5 30
a Caduet 5/80 AS MP NP 30 5 30
Tablet 10 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) Oral a Cadivast 10/10 AF MP NP 30 5 30
a Caduet 10/10 AS MP NP 30 5 30
Tablet 10 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) Oral a Cadivast 10/20 AF MP NP 30 5 30
a Caduet 10/20 AS MP NP 30 5 30
Tablet 10 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) Oral a Cadivast 10/40 AF MP NP 30 5 30
a Caduet 10/40 AS MP NP 30 5 30
Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) Oral a Cadivast 10/80 AF MP NP 30 5 30
a Caduet 10/80 AS MP NP 30 5 30
Amlodipine with valsartan Tablet 5 mg (as besilate)‑80 mg Oral a Exforge 5/80 NV MP NP C4373 28 5 28
a Valsartan/Amlodipine Novartis 80/5 NM MP NP C4373 28 5 28
Tablet 5 mg (as besilate)‑160 mg Oral a Exforge 5/160 NV MP NP C4373 28 5 28
a Valsartan/Amlodipine Novartis 160/5 NM MP NP C4373 28 5 28
Tablet 5 mg (as besilate)‑320 mg Oral a Exforge 5/320 NV MP NP C4373 28 5 28
a Valsartan/Amlodipine Novartis 320/5 NM MP NP C4373 28 5 28
Tablet 10 mg (as besilate)‑160 mg Oral a Exforge 10/160 NV MP NP C4373 28 5 28
a Valsartan/Amlodipine Novartis 160/10 NM MP NP C4373 28 5 28
Tablet 10 mg (as besilate)‑320 mg Oral a Exforge 10/320 NV MP NP C4373 28 5 28
a Valsartan/Amlodipine Novartis 320/10 NM MP NP C4373 28 5 28
Amlodipine with valsartan and hydrochlorothiazide Tablet 5 mg (as besilate)‑160 mg‑12.5 mg Oral a Exforge HCT 5/160/12.5 NV MP NP C4311 28 5 28
a Valsartan/Amlodipine/HCT Novartis 160/5/12.5 NM MP NP C4311 28 5 28
Tablet 5 mg (as besilate)‑160 mg‑25 mg Oral a Exforge HCT 5/160/25 NV MP NP C4311 28 5 28
a Valsartan/Amlodipine/HCT Novartis 160/5/25 NM MP NP C4311 28 5 28
Tablet 10 mg (as besilate)‑160 mg‑12.5 mg Oral a Exforge HCT 10/160/12.5 NV MP NP C4311 28 5 28
a Valsartan/Amlodipine/HCT Novartis 160/10/12.5 NM MP NP C4311 28 5 28
Tablet 10 mg (as besilate)‑160 mg‑25 mg Oral a Exforge HCT 10/160/25 NV MP NP C4311 28 5 28
a Valsartan/Amlodipine/HCT Novartis 160/10/25 NM MP NP C4311 28 5 28
Tablet 10 mg (as besilate)‑320 mg‑25 mg Oral a Exforge HCT 10/320/25 NV MP NP C4311 28 5 28
a Valsartan/Amlodipine/HCT Novartis 320/10/25 NM MP NP C4311 28 5 28
Amoxicillin Capsule 250 mg (as trihydrate) Oral a Alphamox 250 AF MP NP MW PDP 20 0 20
a AMILOXYN RF MP NP MW PDP 20 0 20
a Amoxil AS MP NP MW PDP 20 0 20
a APO‑Amoxycillin TX MP NP MW PDP 20 0 20
a Cilamox AL MP NP MW PDP 20 0 20
a Alphamox 250 AF MP NP P10404 40
CN10404 		0
CN10404 		20
a AMILOXYN RF MP NP P10404 40
CN10404 		0
CN10404 		20
a Amoxil AS MP NP P10404 40
CN10404 		0
CN10404 		20
a APO‑Amoxycillin TX MP NP P10404 40
CN10404 		0
CN10404 		20
a Cilamox AL MP NP P10404 40
CN10404 		0
CN10404 		20
Capsule 500 mg (as trihydrate) Oral a Alphamox 500 AF MP NP MW PDP 20 0 20
a AMILOXYN RF MP NP MW PDP 20 0 20
a Amoxil AS MP NP MW PDP 20 0 20
a Amoxycillin generichealth 500 GQ MP NP MW PDP 20 0 20
a Amoxycillin Sandoz SZ MP NP MW PDP 20 0 20
a APO‑Amoxycillin TX MP NP MW PDP 20 0 20
a Cilamox AL MP NP MW PDP 20 0 20
a NOUMED AMOXICILLIN VO MP NP MW PDP 20 0 20
a Alphamox 500 AF MP NP P10402 40
CN10402 		0
CN10402 		20
a AMILOXYN RF MP NP P10402 40
CN10402 		0
CN10402 		20
a Amoxil AS MP NP P10402 40
CN10402 		0
CN10402 		20
a Amoxycillin generichealth 500 GQ MP NP P10402 40
CN10402 		0
CN10402 		20
a Amoxycillin Sandoz SZ MP NP P10402 40
CN10402 		0
CN10402 		20
a APO‑Amoxycillin TX MP NP P10402 40
CN10402 		0
CN10402 		20
a Cilamox AL MP NP P10402 40
CN10402 		0
CN10402 		20
a NOUMED AMOXICILLIN VO MP NP P10402 40
CN10402 		0
CN10402 		20
Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL Oral Amoxil AS PDP 1 0 1
MP NP 1 1 1
MP NP P5863 1
CN5863 		1
CN5863 		1
Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL Oral a Amoxil AS PDP 1 0 1
a APO‑Amoxycillin TX PDP 1 0 1
a NOUMED AMOXICILLIN VO PDP 1 0 1
a Amoxil AS MP NP 1 1 1
a APO‑Amoxycillin TX MP NP 1 1 1
a NOUMED AMOXICILLIN VO MP NP 1 1 1
Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL Oral Amoxil Forte AS PDP 1 0 1
Amoxycillin Sandoz SZ PDP 1 0 1
APO‑Amoxycillin TX PDP 1 0 1
Cilamox AL PDP 1 0 1
NOUMED AMOXICILLIN VO PDP 1 0 1
Amoxil Forte AS MP NP 1 1 1
Amoxycillin Sandoz SZ MP NP 1 1 1
APO‑Amoxycillin TX MP NP 1 1 1
Cilamox AL MP NP 1 1 1
NOUMED AMOXICILLIN VO MP NP 1 1 1
Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL (s19A) Oral Amoxicillin 250mg/5 ml Oral Suspension Sugar Free BP (Kent) RQ PDP 1 0 1
MP NP 1 1 1
Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL Oral Maxamox SZ PDP 1 0 1
MP NP 1 1 1
Tablet 1 g (as trihydrate) Oral a Amoxycillin Sandoz BG MP NP C5843 C10416 14 1 14
a Maxamox SZ MP NP C5843 C10416 14 1 14
Amoxicillin with clavulanic acid Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL Oral Curam SZ PDP C5833 C5894 1 0 1
MP NP C5832 C5893 1 1 1
Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL Oral a Augmentin Duo 400 AS PDP C5833 C5894 1 0 1
a Curam Duo SZ PDP C5833 C5894 1 0 1
a Augmentin Duo 400 AS MP NP C5832 C5893 1 1 1
a Curam Duo SZ MP NP C5832 C5893 1 1 1
Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) Oral a AlphaClav Duo AF MP NP C5832 C5893 C10405 P5832 P5893 10 0 10
MW C5832 C5893 10 0 10
PDP C5833 C5894 10 0 10
a AMCLAVOX DUO 500/125 RW MP NP C5832 C5893 C10405 P5832 P5893 10 0 10
MW C5832 C5893 10 0 10
PDP C5833 C5894 10 0 10
a Amoxycillin/Clavulanic Acid 500/125 APOTEX TY MP NP C5832 C5893 C10405 P5832 P5893 10 0 10
MW C5832 C5893 10 0 10
PDP C5833 C5894 10 0 10
a Amoxyclav AN 500/125 EA MP NP C5832 C5893 C10405 P5832 P5893 10 0 10
MW C5832 C5893 10 0 10
PDP C5833 C5894 10 0 10
a APO‑Amoxycillin/ Clavulanic Acid 500/125 TX MP NP C5832 C5893 C10405 P5832 P5893 10 0 10
MW C5832 C5893 10 0 10
PDP C5833 C5894 10 0 10
a APO-AMOXY/CLAV 500/125 TW MP NP C5832 C5893 C10405 P5832 P5893 10 0 10
MW C5832 C5893 10 0 10
PDP C5833 C5894 10 0 10
a APX-Amoxicillin/Clavulanic Acid XT MP NP C5832 C5893 C10405 P5832 P5893 10 0 10
MW C5832 C5893 10 0 10
PDP C5833 C5894 10 0 10
a Augmentin Duo AS MP NP C5832 C5893 C10405 P5832 P5893 10 0 10
MW C5832 C5893 10 0 10
PDP C5833 C5894 10 0 10
a Curam Duo 500/125 SZ MP NP C5832 C5893 C10405 P5832 P5893 10 0 10
MW C5832 C5893 10 0 10
PDP C5833 C5894 10 0 10
a AlphaClav Duo AF MP NP C5832 C5893 C10405 P10405 20 0 10
a AMCLAVOX DUO 500/125 RW MP NP C5832 C5893 C10405 P10405 20 0 10
a Amoxycillin/Clavulanic Acid 500/125 APOTEX TY MP NP C5832 C5893 C10405 P10405 20 0 10

Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.

If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.

Endnote 2—Abbreviation key

ad = added or inserted o = order(s)
am = amended Ord = Ordinance
amdt = amendment orig = original
c = clause(s) par = paragraph(s)/subparagraph(s)
C[x] = Compilation No. x /sub‑subparagraph(s)
Ch = Chapter(s) pres = present
def = definition(s) prev = previous
Dict = Dictionary (prev…) = previously
disallowed = disallowed by Parliament Pt = Part(s)
Div = Division(s) r = regulation(s)/rule(s)
ed = editorial change reloc = relocated
exp = expires/expired or ceases/ceased to have renum = renumbered
effect rep = repealed
F = Federal Register of Legislation rs = repealed and substituted
gaz = gazette s = section(s)/subsection(s)
LA = Legislation Act 2003 Sch = Schedule(s)
LIA = Legislative Instruments Act 2003 Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given SLI = Select Legislative Instrument
effect SR = Statutory Rules
(md not incorp) = misdescribed amendment Sub‑Ch = Sub‑Chapter(s)
cannot be given effect SubPt = Subpart(s)
mod = modified/modification underlining = whole or part not
No. = Number(s) commenced or to be commenced

Endnote 3—Legislation history

Name Registration Commencement Application, saving and transitional provisions
PB 71 of 2012 28 Sept 2012 (F2012L01982) 1 Oct 2012 (s 2)
PB 93 of 2012 29 Nov 2012 (F2012L02291) 1 Dec 2012 (s 2) —
PB 108 of 2012 18 Dec 2012 (F2012L02512) 1 Jan 2013 (s 2) —
PB 1 of 2013 10 Jan 2013 (F2013L00039) 1 Feb 2013 (s 2) —
PB 4 of 2013 21 Jan 2013 (F2013L00072) 22 Jan 2013 (s 2) —
PB 8 of 2013 14 Feb 2013 (F2013L00185) 1 Mar 2013 (s 2) —
PB 14 of 2013 27 Mar 2013 (F2013L00566) 1 Apr 2013 (s 2) —
PB 21 of 2013 24 Apr 2013 (F2013L00685) 1 May 2013 (s 2) —
PB 29 of 2013 24 May 2013 (F2013L00843) 1 June 2013 (s 2) —
PB 35 of 2013 5 June 2013 (F2013L00922) 1 July 2013 (s 2) —
PB 39 of 2013 21 June 2013 (F2013L01096) 1 July 2013 (s 2) —
PB 40 of 2013 29 July 2013 (F2013L01460) 1 Aug 2013 (s 2) —
PB 53 of 2013 16 Aug 2013 (F2013L01580) 1 Sept 2013 (s 2) —
PB 61 of 2013 10 Sept 2013 (F2013L01682) 1 Oct 2013 (s 2) —
PB 69 of 2013 4 Oct 2013 (F2013L01768) 1 Nov 2013 (s 2) —
PB 74 of 2013 29 Nov 2013 (F2013L02013) 1 Dec 2013 (s 2) —
PB 88 of 2013 20 Dec 2013 (F2013L02170) 1 Jan 2014 (s 2) —
PB 1 of 2014 10 Jan 2014 (F2014L00051) 1 Feb 2014 (s 2) —
PB 9 of 2014 17 Feb 2014 (F2014L00147) 1 Mar 2014 (s 2) —
PB 17 of 2014 26 Mar 2014 (F2014L00342) 1 Apr 2014 (s 2) —
PB 27 of 2014 11 Apr 2014 (F2014L00399) 1 May 2014 (s 2) —
PB 36 of 2014 21 May 2014 (F2014L00588) 1 June 2014 (s 2) —
PB 45 of 2014 20 June 2014 (F2014L00763) 1 July 2014 (s 2) —
PB 51 of 2014 1 July 2014 (F2014L00921) 1 July 2014 (s 2) —
PB 52 of 2014 31 July 2014 (F2014L01058) 1 Aug 2014 (s 2) —
PB 61 of 2014 25 Aug 2014 (F2014L01121) 1 Sept 2014 (s 2) —
PB 72 of 2014 30 Sept 2014 (F2014L01298) 1 Oct 2014 (s 2) —
PB 82 of 2014 24 Oct 2014 (F2014L01395) 1 Nov 2014 (s 2) —
PB 88 of 2014 28 Nov 2014 (F2014L01602) 1 Dec 2014 (s 2) —
PB 101 of 2014 22 Dec 2014 (F2014L01780) 1 Jan 2015 (s 2) —
PB 109 of 2014 23 Dec 2014 (F2014L01795) 1 Jan 2015 (s 2) —
PB 1 of 2015 14 Jan 2015 (F2015L00040) 1 Feb 2015 (s 2) —
PB 10 of 2015 25 Feb 2015 (F2015L00205) 1 Mar 2015 (s 2) —
PB 26 of 2015 26 Mar 2015 (F2015L00342) 1 Apr 2015 (s 2) —
PB 39 of 2015 24 Apr 2015 (F2015L00595) 1 May 2015 (s 2) —
PB 47 of 2015 29 May 2015 (F2015L00762) 1 June 2015 (s 2) —
PB 55 of 2015 30 June 2015 (F2015L01058) 1 July 2015 (s 2) —
PB 68 of 2015 31 July 2015 (F2015L01212) 1 Aug 2015 (s 2) —
PB 78 of 2015 28 Aug 2015 (F2015L01351) 1 Sept 2015 (s 2) —
PB 90 of 2015 29 Sept 2015 (F2015L01520) 1 Oct 2015 (s 2) —
PB 101 of 2015 27 Oct 2015 (F2015L01701) 1 Nov 2015 (s 2) —
PB 107 of 2015 30 Nov 2015 (F2015L01878) 1 Dec 2015 (s 2) —
PB 117 of 2015 24 Dec 2015 (F2015L02141) 1 Jan 2016 (s 2) —
PB 1 of 2016 1 Feb 2016 (F2016L00075) 1 Feb 2016 (s 2) —
PB 11 of 2016 23 Feb 2016 (F2016L00136) 1 Mar 2016 (s 2) —
PB 18 of 2016 1 Apr 2016 (F2016L00470) 1 Apr 2016 (s 2) —
PB 29 of 2016 29 Apr 2016 (F2016L00604) 1 May 2016 (s 2) —
PB 41 of 2016 30 May 2016 (F2016L00856) 1 June 2016 (s 2) —
PB 52 of 2016 22 June 2016 (F2016L01056) 1 July 2016 (s 2) —
PB 62 of 2016 19 July 2016 (F2016L01185) 1 Aug 2016 (s 2) —
PB 72 of 2016 18 Aug 2016 (F2016L01296) 1 Sept 2016 (s 2) —
PB 81 of 2016 30 Sept 2016 (F2016L01560) 1 Oct 2016 (s 2) —
PB 90 of 2016 31 Oct 2016 (F2016L01689) 1 Nov 2016 (s 2) —
PB 97 of 2016 30 Nov 2016 (F2016L01832) 1 Dec 2016 (s 2) —
PB 110 of 2016 22 Dec 2016 (F2016L02026) 1 Jan 2017 (s 2) —
PB 1 of 2017 25 Jan 2017 (F2017L00070) 1 Feb 2017 (s 2) —
PB 15 of 2017 30 Mar 2017 (F2017L00362) 1 Apr 2017 (s 2) —
PB 26 of 2017 28 Apr 2017 (F2017L00483) 1 May 2017 (s 2) —
PB 34 of 2017 31 May 2017 (F2017L00625) 1 June 2017 (s 2) —
PB 45 of 2017 29 June 2017 (F2017L00825) 1 July 2017 (s 2) —
PB 55 of 2017 25 July 2017 (F2017L00948) 1 Aug 2017 (s 2) —
PB 62 of 2017 29 Aug 2017 (F2017L01098) 1 Sept 2017 (s 2) —
PB 71 of 2017 26 Sept 2017 (F2017L01264) 1 Oct 2017 (s 2) —
PB 84 of 2017 23 Oct 2017 (F2017L01383) 1 Nov 2017 (s 2) —
PB 92 of 2017 29 Nov 2017 (F2017L01548) 1 Dec 2017 (s 2) —
PB 101 of 2017 18 Dec 2017 (F2017L01644) 1 Jan 2018 (s 2) —
PB 1 of 2018 24 Jan 2018 (F2018L00057) 1 Feb 2018 (s 2) —
PB 8 of 2018 20 Feb 2018 (F2018L00129) 21 Feb 2018 (s 2) —
PB 12 of 2018 28 Feb 2018 (F2018L00161) 1 Mar 2018 (s 2) —
PB 19 of 2018 28 Mar 2018 (F2018L00420) 1 Apr 2018 (s 2) —
PB 29 of 2018 27 Apr 2018 (F2018L00532) 1 May 2018 (s 2) —
PB 36 of 2018 31 May 2018 (F2018L00685) 1 June 2018 (s 2) —
PB 50 of 2018 29 June 2018 (F2018L00956) 1 July 2018 (s 2) —
PB 63 of 2018 31 July 2018 (F2018L01071) 1 Aug 2018 (s 2) —
PB 74 of 2018 30 Aug 2018 (F2018L01223) 1 Sept 2018 (s 2) —
PB 83 of 2018 27 Sept 2018 (F2018L01359) 1 Oct 2018 (s 2) —
PB 91 of 2018 29 Oct 2018 (F2018L01491) 1 Nov 2018 (s 2) —
PB 99 of 2018 29 Nov 2018 (F2018L01625) 1 Dec 2018 (s 2) —
PB 110 of 2018 19 Dec 2018 (F2018L01802) 1 Jan 2019 (s 2) —
PB 1 of 2019 31 Jan 2019 (F2019L00073) 1 Feb 2019 (s 2) —
PB 10 of 2019 27 Feb 2019 (F2019L00211) 1 Mar 2019 (s 2) —
PB 17 of 2019 29 Mar 2019 (F2019L00472) 1 Apr 2019 (s 2) —
PB 28 of 2019 30 Apr 2019 (F2019L00663) 1 May 2019 (s 2) —
PB 36 of 2019 31 May 2019 (F2019L00713) 1 June 2019 (s 2) —
PB 46 of 2019 28 June 2019 (F2019L00907) 1 July 2019 (s 2) —
PB 58 of 2019 30 July 2019 (F2019L01020) 1 Aug 2019 (s 2) —
PB 66 of 2019 30 Aug 2019 (F2019L01129) 1 Sept 2019 (s 2) —
PB 76 of 2019 30 Sept 2019 (F2019L01291) 1 Oct 2019 (s 2) —
PB 84 of 2019 31 Oct 2019 (F2019L01394) 1 Nov 2019 (s 2) —
PB 92 of 2019 28 Nov 2019 (F2019L01520) 1 Dec 2019 (s 2) —
PB 104 of 2019 23 Dec 2019 (F2019L01690) 1 Jan 2020 (s 2) —
PB 1 of 2020 30 Jan 2020 (F2020L00069) 1 Feb 2020 (s 2) —
PB 14 of 2020 28 Feb 2020 (F2020L00184) 1 Mar 2020 (s 2) —
PB 20 of 2020 31 Mar 2020 (F2020L00365) 1 Apr 2020 (s 2) —
PB 32 of 2020 30 Apr 2020 (F2020L00531) 1 May 2020 (s 2(1) item 1) —
PB 33 of 2020 30 Apr 2020 (F2020L00523) 1 May 2020 (s 2) —
PB 42 of 2020 29 May 2020 (F2020L00641) 1 June 2020 (s 2) —
PB 55 of 2020 29 June 2020 (F2020L00841) 1 July 2020 (s 2) —
PB 67 of 2020 31 July 2020 (F2020L00968) 1 Aug 2020 (s 2) —
PB 78 of 2020 27 Aug 2020 (F2020L01068) 1 Sept 2020 (s 2) —
PB 100 of 2020 29 Sept 2020 (F2020L01247) Sch 1 (items 1, 2): 30 Sept 2020 (s 2(1) item 1)) —
PB 89 of 2020 30 Sept 2020 (F2020L01268) 1 Oct 2020 (s 2) —
PB 102 of 2020 30 Oct 2020 (F2020L01365) 1 Nov 2020 (s 2) —
PB 109 of 2020 30 Oct 2020 (F2020L01366) Sch 1 (items 1–5): 1 Nov 2020 (s 2(1) item 2) —
PB 111 of 2020 27 Nov 2020 (F2020L01490) 1 Dec 2020 (s 2) —
PB 124 of 2020 23 Dec 2020 (F2020L01691) 1 Jan 2021 (s 2) —
PB 1 of 2021 28 Jan 2021 (F2021L00076) 1 Feb 2021 (s 2) —
PB 13 of 2021 28 Feb 2021 (F2021L00166) 1 Mar 2021 (s 2) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 3) (PB 22 of 2021) 31 Mar 2021 (F2021L00396) 1 Apr 2021 (s 2) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 4) (PB 38 of 2021) 30 Apr 2021 (F2021L00517) 1 May 2021 (s 2) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 5) (PB 46 of 2021) 28 May 2021 (F2021L00654) 1 June 2021 (s 2) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 6) (PB 60 of 2021) 30 June 2021 (F2021L00904) 1 July 2021 (s 2) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 7) (PB 74 of 2021) 31 July 2021 (F2021L01057) Sch 1: 1 Nov 2020 (s 2(1) item 2)
Remainder: 1 Aug 2021 (s 2(1) items 1, 3) 		—
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 8) (PB 87 of 2021) 31 Aug 2021 (F2021L01218) 1 Sept 2021 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 9) (PB 97 of 2021) 30 Sept 2021 (F2021L01369) 1 Oct 2021 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 10) (PB 109 of 2021) 31 Oct 2021 (F2021L01485) 1 Nov 2021 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 11) (PB 118 of 2021) 30 Nov 2021 (F2021L01649) 1 Dec 2021 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2021 (No. 12) (PB 128 of 2021) 24 Dec 2021 (F2021L01902) 1 Jan 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 1) (PB 1 of 2022) 31 Jan 2022 (F2022L00091) 1 Feb 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 2) (PB 11 of 2022) 28 Feb 2022 (F2022L00203) 1 Mar 2022 (s 2(1) item 1) —
National Health Legislation Amendment (Authority Required Procedures for Prescriptions) Instrument 2022 (PB 21 of 2022) 28 Feb 2022 (F2022L00208) Sch 1 (item 2): 1 Mar 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 3) (PB 23 of 2022) 31 Mar 2022 (F2022L00454) 1 Apr 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 4) (PB 33 of 2022) 29 Apr 2022 (F2022L00642) 1 May 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 5) (PB 43 of 2022) 27 May 2022 (F2022L00724) 1 June 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 6) (PB 54 of 2022) 30 June 2022 (F2022L00878) 1 July 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 7) (PB 66 of 2022) 10 July 2022 (F2022L00963) 11 July 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 8) (PB 67 of 2022) 29 July 2022 (F2022L01026) 1 Aug 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 9) (PB 78 of 2022) 26 Aug 2022 (F2022L01119) 1 Sept 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 10) (PB 85 of 2022) 30 Sept 2022 (F2022L01291) 1 Oct 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 11) (PB 99 of 2022) 31 Oct 2022 (F2022L01408) 1 Nov 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 12) (PB 111 of 2022) 30 Nov 2022 (F2022L01546) 1 Dec 2022 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2022 (No. 13) (PB 120 of 2022) 23 Dec 2022 (F2022L01759) 1 Jan 2023 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 1) (PB 1 of 2023) 31 Jan 2023 (F2023L00072) 1 Feb 2023 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 2) (PB 11 of 2023) 28 Feb 2023 (F2023L00162) 1 Mar 2023 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 3) (PB 21 of 2023) 31 Mar 2023 (F2023L00384) 1 Apr 2023 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 4) (PB 34 of 2023) 28 Apr 2023 (F2023L00493) 1 May 2023 (s 2(1) item 1) —
National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2023 (No. 5) (PB 43 of 2023) 31 May 2023 (F2023L00646) 1 June 2023 (s 2(1) item 1) —

Endnote 4—Amendment history

Provision affected How affected
s 2............................................. rep LIA s 48D
s 3............................................. rep LIA s 48C
s 4............................................. am PB 93 of 2012; PB 26 and 55 of 2015; PB 11 of 2016; PB 83 of 2018
ed C72
am PB 67 of 2020; F2021L01057; F2021L01485
s 9............................................. am PB 8 of 2018; PB 109 of 2020
s 9A.......................................... ad F2021L01057
s 10........................................... am PB 32 of 2020
(3A) rep 1 July 2022 (s 10A(3))
s 10A........................................ ad PB 32 of 2020
am PB 100 of 2020; F2021L00396; F2021L01902
rep 1 July 2022 (s 10A(3))
s 11........................................... am PB 26 of 2015; PB 29 of 2016
s 12........................................... am PB 26 of 2015; PB 29 of 2016; PB 67 of 2020; F2022L00208
s 13........................................... am PB 26 of 2015; PB 29 of 2016
s 14........................................... am PB 26 of 2015
Schedule 1
Schedule 1................................ am PB 93 and 108 of 2012; PB 1, 4, 8, 14, 21, 29, 35, 39, 40, 53, 61, 69, 74 and 88 of 2013; PB 1, 9, 17, 27, 36, 45, 51, 52, 61, 72, 82, 88, 101 and 109 of 2014; PB 1, 10 and 26 of 2015; PB 39, 47, 55, 68 (Sch 1 par 9(e) md), 78, 90, 101, 107 and 117 of 2015; PB 1, 11, 18, 29, 41, 52, 62, 72, 81 (Sch 1 item 56 md), 90, 97 and 110 of 2016
ed C51
am PB 1 of 2017
ed C53
am PB 15 of 2017; PB 26 of 2017; PB 34 of 2017; PB 45 of 2017 (Sch 1 item 10 md incorp); PB 55 of 2017; PB 62 of 2017; PB 71 of 2017; PB 84 of 2017; PB 92 of 2017; PB 101 of 2017; PB 1 of 2018; PB 12 of 2018; PB 19 of 2018; PB 29 of 2018; PB 36 of 2018
rs PB 50 of 2018
am PB 63 of 2018; PB 74 of 2018; PB 83 of 2018
ed C72
am PB 91 of 2018; PB 99 of 2018; PB 110 of 2018; PB 1 of 2019
ed C76
am PB 10 of 2019; PB 17 of 2019; PB 28 of 2019
ed C79
am PB 36 of 2019; PB 46 of 2019; PB 58 of 2019; PB 66 of 2019
ed C83
am PB 76 of 2019
ed C84
am PB 84 of 2019; PB 92 of 2019; PB 104 of 2019; PB 1 of 2020; PB 14 of 2020; PB 20 of 2020; PB 33 of 2020; PB 42 of 2020; PB 55 of 2020; PB 67 of 2020; PB 78 of 2020; PB 89 of 2020; PB 102 of 2020; PB 109 of 2020; PB 111 of 2020; PB 124 of 2020; PB 1 of 2021; PB 13 of 2021; F2021L00396; F2021L00517; F2021L00654; F2021L00904; F2021L01057; F2021L01218; F2021L01369; F2021L01485; F2021L01649; F2021L01902
ed C112
am F2022L00091; F2022L00203
ed C115
am F2022L00454
ed C116
am F2022L00642; F2022L00724; F2022L00878; F2022L00963; F2022L01026; F2022L01119
ed C122
am F2022L01291; F2022L01408; F2022L01546; F2022L01759; F2023L00072; F2023L00162; F2023L00384; F2023L00493; F2023L00646 (Sch 1 item 30 md not incorp)
ed C131
Schedule 2
Schedule 2................................ am PB 68 and 90 of 2015; F2021L01057
Schedule 3
Schedule 3................................ am PB 93 and 108 of 2012; PB 1, 8, 14, 29, 40, 61, 74 and 88 of 2013; PB 1, 9, 17, 36, 45, 52, 61, 72, 82, 88 and 101 of 2014; PB 1, 10, 26, 39, 47, 55, 68, 78, 90, 101, 107 and 117 of 2015; PB 1, 11, 18, 41, 52, 62, 81, 97 and 110 of 2016; PB 1 of 2017; PB 15 of 2017; PB 26 of 2017; PB 34 of 2017; PB 45 of 2017; PB 84 of 2017; PB 92 of 2017; PB 101 of 2017; PB 12 of 2018; PB 19 of 2018; PB 29 of 2018; PB 36 of 2018; PB 63 of 2018; PB 74 of 2018; PB 83 of 2018; PB 91 of 2018; PB 99 of 2018; PB 110 of 2018; PB 1 of 2019; PB 10 of 2019; PB 17 of 2019; PB 28 of 2019; PB 36 of 2019; PB 46 of 2019; PB 58 of 2019
ed C82
am PB 66 of 2019; PB 76 of 2019; PB 84 of 2019; PB 92 of 2019; PB 104 of 2019; PB 14 of 2020; PB 20 of 2020; PB 55 of 2020; PB 67 of 2020; PB 78 of 2020; PB 102 of 2020; PB 111 of 2020; PB 1 of 2021; F2021L00396; F2021L00517; F2021L00904; F2021L01057; F2021L01218; F2021L01369; F2021L01485; F2021L01649; F2021L01902; F2022L00091; F2022L00203; F2022L00454; F2022L00642; F2022L00724; F2022L00878; F2022L01026; F2022L01119; F2022L01408; F2022L01546; F2023L00072; F2023L00162; F2023L00384; F2023L00646
Schedule 4
Schedule 4................................ am PB 93 and 108 of 2012; PB 1, 8, 14, 21, 29, 35, 40, 53, 61, 69, 74 and 88 of 2013; PB 1, 9, 17, 27, 36, 45, 52, 61, 72, 82, 88 and 101 of 2014; PB 1, 10, 26, 39, 47, 55, 68, 78, 90, 101, 107 and 117 of 2015; PB 1, 11, 18, 29, 41, 52, 62, 72, 81, 90, 97 and 110 of 2016; PB 1 of 2017; PB 15 of 2017; PB 26 of 2017; PB 34 of 2017 (Sch 1 item 124 md not incorp); PB 45 of 2017; PB 55 of 2017; PB 62 of 2017; PB 71 of 2017; PB 84 of 2017; PB 92 of 2017; PB 101 of 2017; PB 1 of 2018; PB 12 of 2018; PB 19 of 2018; PB 29 of 2018; PB 36 of 2018; PB 50 of 2018; PB 63 of 2018; PB 74 of 2018; PB 83 of 2018; PB 91 of 2018; PB 99 of 2018; PB 110 of 2018; PB 1 of 2019; PB 10 of 2019; PB 17 of 2019; PB 28 of 2019; PB 36 of 2019 (Sch 1 par 50(a), (c), (g)–(i) md not incorp); PB 46 of 2019; PB 58 of 2019; PB 66 of 2019; PB 76 of 2019
ed C84
am PB 84 of 2019; PB 92 of 2019; PB 104 of 2019; PB 1 of 2020; PB 14 of 2020; PB 20 of 2020; PB 33 of 2020; PB 42 of 2020; PB 55 of 2020; PB 67 of 2020; PB 78 of 2020; PB 89 of 2020; PB 102 of 2020; PB 111 of 2020; PB 124 of 2020; PB 1 of 2021; PB 13 of 2021; F2021L00396; F2021L00517; F2021L00654; F2021L00904; F2021L01057; F2021L01218; F2021L01369; F2021L01485
ed C111
am F2021L01649; F2021L01902; F2022L00091; F2022L00203; F2022L00454; F2022L00642
ed C117
am F2022L00724; F2022L00878; F2022L00963; F2022L01026; F2022L01119; F2022L01291
ed C123
am F2022L01408; F2022L01546; F2022L01759; F2023L00072; F2023L00162; F2023L00384; F2023L00493; F2023L00646
Schedule 5
Schedule 5................................ ad PB 107, 2015
am PB 1, 11, 18, 29, 41, 52, 62, 72, 81, 90 and 97 of 2016; PB 1 of 2017; PB 15 of 2017; PB 26 of 2017; PB 34 of 2017; PB 45 of 2017; PB 55 of 2017; PB 62 of 2017; PB 71 of 2017; PB 84 of 2017; PB 92 of 2017; PB 101 of 2017; PB 1 of 2018; PB 12 of 2018; PB 19 of 2018 (Sch 1 item 127 md not incorp); PB 29 of 2018; PB 36 of 2018
rs PB 50 of 2018
am PB 63 of 2018 (amdt never applied (Sch 1 item 134)); PB 74 of 2018; PB 83 of 2018; PB 91 of 2018; PB 99 of 2018; PB 110 of 2018; PB 1 of 2019; PB 10 of 2019; PB 17 of 2019; PB 28 of 2019
ed C79
am PB 46 of 2019; PB 58 of 2019; PB 66 of 2019; PB 76 of 2019; PB 84 of 2019; PB 92 of 2019; PB 104 of 2019; PB 1 of 2020; PB 14 of 2020
ed C89
am PB 20 of 2020; PB 42 of 2020; PB 55 of 2020; PB 67 of 2020; PB 78 of 2020; PB 89 of 2020; PB 102 of 2020; PB 111 of 2020; PB 124 of 2020; PB 1 of 2021; PB 13 of 2021; F2021L00396; F2021L00517; F2021L00654; F2021L00904; F2021L01057; F2021L01218; F2021L01369; F2021L01485; F2021L01649
ed C112
am F2021L01902; F2022L00091
ed C114
am F2022L00203; F2022L00454
ed C116
am F2022L00642
ed C118
am F2022L00724; F2022L00878; F2022L01119; F2022L01291; F2022L01408; F2022L01546; F2022L01759; F2023L00072; F2023L00162; F2023L00384; F2023L00646 (Sch 1 items 133–136 md not incorp)
Schedule 6................................ ad PB 32 of 2020
am PB 42 of 2020; PB 100 of 2020; F2021L00396; F2021L00654; F2021L00904
ed C106
am F2021L01649; F2021L01902; F2022L00203
rep 1 July 2022 (s 10A(3))

Endnote 5—Editorial changes

In preparing this compilation for registration, the following kinds of editorial change(s) were made under the Legislation Act 2003.

Schedule 1, Part 1, entry for Fentanyl in the form Transdermal patch 7.65 mg

Kind of editorial change

Reordering of provisions

Details of editorial change

In Part 1 of Schedule 1, the entry for Fentanyl in the form Transdermal patch 7.65 mg appears after the entries for Fentanyl in the forms Transdermal patch 8.25 mg and Transdermal patch 8.4 mg.

This compilation was editorially changed to move the entry for Fentanyl in the form Transdermal patch 7.65 mg to the correct alphanumerical position.

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0